Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - BOOK LB - 1. AU - Scarborough, P AU - Bhatnagar, P AU - Wickramasinghe, K AU - Smolina, K AU - Mitchell, C AU - Rayner, M TI - Coronary Heart Disease Statistics 2010 ET - 2010 edn. CY - London PB - British Heart Foundation PY - 2010 ER - TY - JOUR LB - 2. AU - Jack, DB TI - One hundred years of aspirin J2 - Lancet PY - 1997 VL - 350 SP - 437 EP - 439 UR - http://dx.doi.org/10.1016/S0140-6736(97)07087-6 ER - TY - BOOK LB - 3. AU - Health and Social Care Information Centre, Prescribing and Primary Care Services TI - Prescriptions Dispensed in the Community: England, Statistics for 2001 to 2011 CY - Leeds PB - Health and Social Care Information Centre PY - 2011 ER - TY - JOUR LB - 4. AU - Baigent, C AU - Blackwell, L AU - Collins, R AU - Emberson, J AU - Godwin, J AU - Peto, R TI - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials J2 - Lancet PY - 2009 VL - 373 SP - 1849 EP - 1860 UR - http://dx.doi.org/10.1016/S0140-6736(09)60503-1 ER - TY - JOUR LB - 5. AU - Eikelboom, JW AU - Hirsh, J AU - Spencer, FA AU - Baglin, TP AU - Weitz, JI TI - Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines J2 - Chest PY - 2012 VL - 141 IS - Suppl. 2 SP - e89 EP - 119 ER - TY - JOUR LB - 6. AU - Bell, AD AU - Roussin, A AU - Cartier, R AU - Chan, WS AU - Douketis, JD AU - Gupta, A TI - The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary J2 - Can J Cardiol PY - 2011 VL - 27 SP - 208 EP - 221 UR - http://dx.doi.org/10.1016/j.cjca.2010.12.033 ER - TY - JOUR LB - 7. AU - American Diabetes Association TI - Standards of medical care in diabetes – 2013 J2 - Diabetes Care PY - 2013 VL - 36 IS - Suppl. 1 SP - 11 EP - 66 UR - http://dx.doi.org/10.2337/dc13-S011 ER - TY - JOUR LB - 8. AU - Pignone, M AU - Alberts, MJ AU - Colwell, JA AU - Cushman, M AU - Inzucchi, SE AU - Mukherjee, D TI - Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation J2 - Diabetes Care PY - 2010 VL - 33 SP - 1395 EP - 1402 UR - http://dx.doi.org/10.2337/dc10-0555 ER - TY - JOUR LB - 9. AU - Michelson, AD TI - Antiplatelet therapies for the treatment of cardiovascular disease J2 - Nat Rev Drug Discov PY - 2010 VL - 9 SP - 154 EP - 169 UR - http://dx.doi.org/10.1038/nrd2957 ER - TY - JOUR LB - 10. AU - Lloyd-Jones, D AU - Adams, RJ AU - Brown, TM AU - Carnethon, M AU - Dai, S AU - De Simone, G TI - Heart disease and stroke statistics – 2010 update: a report from the American Heart Association J2 - Circulation PY - 2010 VL - 121 SP - e46 EP - 215 UR - http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192667 ER - TY - JOUR LB - 11. AU - Goldstein, LB AU - Bushnell, CD AU - Adams, RJ AU - Appel, LJ AU - Braun, LT AU - Chaturvedi, S TI - Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association J2 - Stroke PY - 2011 VL - 42 SP - 517 EP - 584 UR - http://dx.doi.org/10.1161/STR.0b013e3181fcb238 ER - TY - JOUR LB - 12. AU - Sigvant, B AU - Wiberg-Hedman, K AU - Bergqvist, D AU - Rolandsson, O AU - Andersson, B AU - Persson, E TI - A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences J2 - J Vasc Surg PY - 2007 VL - 45 SP - 1185 EP - 1191 UR - http://dx.doi.org/10.1016/j.jvs.2007.02.004 ER - TY - JOUR LB - 13. AU - Tendera, M AU - Aboyans, V AU - Bartelink, ML AU - Baumgartner, I AU - Clement, D AU - Collet, JP TI - ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) J2 - Eur Heart J PY - 2011 VL - 32 SP - 2851 EP - 2906 UR - http://dx.doi.org/10.1093/eurheartj/ehr211 ER - TY - JOUR LB - 14. AU - Lordkipanidzé, M TI - Advances in monitoring of aspirin therapy J2 - Platelets PY - 2012 VL - 23 SP - 526 EP - 536 UR - http://dx.doi.org/10.3109/09537104.2012.711865 ER - TY - JOUR LB - 15. AU - Awtry, EH AU - Loscalzo, J TI - Aspirin J2 - Circulation PY - 2000 VL - 101 SP - 1206 EP - 1218 UR - http://dx.doi.org/10.1161/01.CIR.101.10.1206 ER - TY - JOUR LB - 16. AU - Vane, JR TI - Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs J2 - Nat New Biol PY - 1971 VL - 231 SP - 232 EP - 235 UR - http://dx.doi.org/10.1038/newbio231232a0 ER - TY - JOUR LB - 17. AU - Roth, GJ AU - Majerus, PW TI - The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein J2 - J Clin Invest PY - 1975 VL - 56 SP - 624 EP - 632 UR - http://dx.doi.org/10.1172/JCI108132 ER - TY - JOUR LB - 18. AU - Patrignani, P AU - Filabozzi, P AU - Patrono, C TI - Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects J2 - J Clin Invest PY - 1982 VL - 69 SP - 1366 EP - 1372 UR - http://dx.doi.org/10.1172/JCI110576 ER - TY - JOUR LB - 19. AU - Laine, L TI - Review article: gastrointestinal bleeding with low-dose aspirin – what’s the risk? J2 - Aliment Pharmacol Ther PY - 2006 VL - 24 SP - 897 EP - 908 UR - http://dx.doi.org/10.1111/j.1365-2036.2006.03077.x ER - TY - JOUR LB - 20. AU - Bertrand, OF AU - Larose, E AU - Rodes-Cabau, J AU - Gleeton, O AU - Taillon, I AU - Roy, L TI - Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy J2 - Am Heart J PY - 2009 VL - 157 SP - 164 EP - 169 UR - http://dx.doi.org/10.1016/j.ahj.2008.09.010 ER - TY - JOUR LB - 21. AU - Suh, JW AU - Mehran, R AU - Claessen, BE AU - Xu, K AU - Baber, U AU - Dangas, G TI - Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J2 - J Am Coll Cardiol PY - 2011 VL - 58 SP - 1750 EP - 1756 UR - http://dx.doi.org/10.1016/j.jacc.2011.07.021 ER - TY - JOUR LB - 22. AU - Patrono, C AU - Andreotti, F AU - Arnesen, H AU - Badimon, L AU - Baigent, C AU - Collet, JP TI - Antiplatelet agents for the treatment and prevention of atherothrombosis J2 - Eur Heart J PY - 2011 VL - 32 SP - 2922 EP - 2932 UR - http://dx.doi.org/10.1093/eurheartj/ehr373 ER - TY - JOUR LB - 23. AU - Hamm, CW AU - Bassand, JP AU - Agewall, S AU - Bax, J AU - Boersma, E AU - Bueno, H TI - ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) J2 - Eur Heart J PY - 2011 VL - 32 SP - 2999 EP - 3054 UR - http://dx.doi.org/10.1093/eurheartj/ehr236 ER - TY - JOUR LB - 24. AU - Smith, SC AU - Jr, Benjamin, EJ AU - Bonow, RO AU - Braun, LT AU - Creager, MA AU - Franklin, BA TI - AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation J2 - Circulation PY - 2011 VL - 124 SP - 2458 EP - 2473 UR - http://dx.doi.org/10.1161/CIR.0b013e318235eb4d ER - TY - JOUR LB - 25. AU - Wright, RS AU - Anderson, JL AU - Adams, CD AU - Bridges, CR AU - Casey, DE, Jr AU - Ettinger, SM TI - 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J2 - Circulation PY - 2011 VL - 123 SP - 2022 EP - 2060 UR - http://dx.doi.org/10.1161/CIR.0b013e31820f2f3e ER - TY - JOUR LB - 26. AU - Wijns, W AU - Kolh, P AU - Danchin, N AU - Di, Mario C AU - Falk, V AU - Folliguet, T TI - Guidelines on myocardial revascularization J2 - Eur Heart J PY - 2010 VL - 31 SP - 2501 EP - 2555 UR - http://dx.doi.org/10.1093/eurheartj/ehq277 ER - TY - JOUR LB - 27. AU - Levine, GN AU - Bates, ER AU - Blankenship, JC AU - Bailey, SR AU - Bittl, JA AU - Cercek, B TI - 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J2 - Circulation PY - 2011 VL - 124 SP - e574 EP - e651 UR - http://dx.doi.org/10.1161/CIR.0b013e31823ba622 ER - TY - JOUR LB - 28. AU - Michelson, AD AU - Cattaneo, M AU - Eikelboom, JW AU - Gurbel, P AU - Kottke-Marchant, K AU - Kunicki, TJ TI - Aspirin resistance: position paper of the Working Group on Aspirin Resistance J2 - J Thromb Haemost PY - 2005 VL - 3 SP - 1309 EP - 1311 UR - http://dx.doi.org/10.1111/j.1538-7836.2005.01351.x ER - TY - JOUR LB - 29. AU - Cattaneo, M TI - Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance J2 - Arterioscler Thromb Vasc Biol PY - 2004 VL - 24 SP - 1980 EP - 1987 UR - http://dx.doi.org/10.1161/01.ATV.0000145980.39477.a9 ER - TY - BOOK LB - 30. AU - European Agency for the Evaluation of Medicinal Products TI - Position Paper on the Regulatory Requirements for the Authorization of Low-Dose Modified Release ASA Formulations in the Secondary Prevention of Cardiovascular Events CY - London PB - European Medicines Agency PY - 2002 ER - TY - JOUR LB - 31. AU - Nakahata, N TI - Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology J2 - Pharmacol Ther PY - 2008 VL - 118 SP - 18 EP - 35 UR - http://dx.doi.org/10.1016/j.pharmthera.2008.01.001 ER - TY - JOUR LB - 32. AU - Grove, EL AU - Storey, RF AU - Wurtz, M TI - Platelet function testing in atherothrombotic disease J2 - Curr Pharm Des PY - 2012 VL - 18 SP - 5379 EP - 5391 UR - http://dx.doi.org/10.2174/138161212803251862 ER - TY - JOUR LB - 33. AU - FitzGerald, GA TI - Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists J2 - Am J Cardiol PY - 1991 VL - 68 SP - 11B EP - 15B UR - http://dx.doi.org/10.1016/0002-9149(91)90379-Y ER - TY - JOUR LB - 34. AU - Crescente, M AU - Di Castelnuovo, A AU - Iacoviello, L AU - De Gaetano, G AU - Cerletti, C TI - PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients J2 - Thromb Haemost PY - 2008 VL - 99 SP - 1129 EP - 1131 UR - http://dx.doi.org/10.1160/TH08-03-0130 ER - TY - JOUR LB - 35. AU - Chan, MV AU - Armstrong, PC AU - Papalia, F AU - Kirkby, NS AU - Warner, TD TI - Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing J2 - Platelets PY - 2011 VL - 22 SP - 485 EP - 494 UR - http://dx.doi.org/10.3109/09537104.2011.592958 ER - TY - JOUR LB - 36. AU - Santilli, F AU - Rocca, B AU - De Cristofaro, R AU - Lattanzio, S AU - Pietrangelo, L AU - Habib, A TI - Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin ‘resistance’ J2 - J Am Coll Cardiol PY - 2009 VL - 53 SP - 667 EP - 677 UR - http://dx.doi.org/10.1016/j.jacc.2008.10.047 ER - TY - JOUR LB - 37. AU - Lordkipanidzé, M AU - Pharand, C AU - Schampaert, E AU - Turgeon, J AU - Palisaitis, DA AU - Diodati, JG TI - A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease J2 - Eur Heart J PY - 2007 VL - 28 SP - 1702 EP - 1708 UR - http://dx.doi.org/10.1093/eurheartj/ehm226 ER - TY - JOUR LB - 38. AU - Tantry, US AU - Bliden, KP AU - Gurbel, PA TI - Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation J2 - J Am Coll Cardiol PY - 2005 VL - 46 SP - 1705 EP - 1709 UR - http://dx.doi.org/10.1016/j.jacc.2005.05.090 ER - TY - JOUR LB - 39. AU - Gurbel, PA AU - Bliden, KP AU - Dichiara, J AU - Newcomer, J AU - Weng, W AU - Neerchal, NK TI - Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study J2 - Circulation PY - 2007 VL - 115 SP - 3156 EP - 3164 UR - http://dx.doi.org/10.1161/CIRCULATIONAHA.106.675587 ER - TY - JOUR LB - 40. AU - Faraday, N AU - Yanek, LR AU - Mathias, R AU - Herrera-Galeano, JE AU - Vaidya, D AU - Moy, TF TI - Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1 J2 - Circulation PY - 2007 VL - 115 SP - 2490 EP - 2496 UR - http://dx.doi.org/10.1161/CIRCULATIONAHA.106.667584 ER - TY - JOUR LB - 41. AU - Harrison, P AU - Segal, H AU - Blasbery, K AU - Furtado, C AU - Silver, L AU - Rothwell, PM TI - Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry J2 - Stroke PY - 2005 VL - 36 SP - 1001 EP - 1005 UR - http://dx.doi.org/10.1161/01.STR.0000162719.11058.bd ER - TY - JOUR LB - 42. AU - Frelinger, AL, III AU - Furman, MI AU - Linden, MD AU - Li, Y AU - Fox, ML AU - Barnard, MR TI - Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance J2 - Circulation PY - 2006 VL - 113 SP - 2888 EP - 2896 UR - http://dx.doi.org/10.1161/CIRCULATIONAHA.105.596627 ER - TY - JOUR LB - 43. AU - Rocca, B AU - Petrucci, G TI - Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms J2 - Thrombosis PY - 2012 VL - 2012 SP - 376721 UR - http://dx.doi.org/10.1155/2012/376721 ER - TY - JOUR LB - 44. AU - Lordkipanidzé, M AU - Pharand, C AU - Palisaitis, DA AU - Diodati, JG TI - Aspirin resistance: truth or dare J2 - Pharmacol Ther PY - 2006 VL - 112 SP - 733 EP - 743 UR - http://dx.doi.org/10.1016/j.pharmthera.2006.05.011 ER - TY - JOUR LB - 45. AU - Schwartz, KA AU - Schwartz, DE AU - Ghosheh, K AU - Reeves, MJ AU - Barber, K AU - DeFranco, A TI - Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction J2 - Am J Cardiol PY - 2005 VL - 95 SP - 973 EP - 975 UR - http://dx.doi.org/10.1016/j.amjcard.2004.12.038 ER - TY - JOUR LB - 46. AU - Cotter, G AU - Shemesh, E AU - Zehavi, M AU - Dinur, I AU - Rudnick, A AU - Milo, O TI - Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? J2 - Am Heart J PY - 2004 VL - 147 SP - 293 EP - 300 UR - http://dx.doi.org/10.1016/j.ahj.2003.07.011 ER - TY - JOUR LB - 47. AU - Yusuf, S AU - Islam, S AU - Chow, CK AU - Rangarajan, S AU - Dagenais, G AU - Diaz, R TI - Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey J2 - Lancet PY - 2011 VL - 378 SP - 1231 EP - 1243 UR - http://dx.doi.org/10.1016/S0140-6736(11)61215-4 ER - TY - JOUR LB - 48. AU - Peace, A AU - McCall, M AU - Tedesco, T AU - Kenny, D AU - Conroy, RM AU - Foley, D TI - The role of weight and enteric coating on aspirin response in cardiovascular patients J2 - J Thromb Haemost PY - 2010 VL - 8 SP - 2323 EP - 2325 UR - http://dx.doi.org/10.1111/j.1538-7836.2010.03997.x ER - TY - JOUR LB - 49. AU - Katona, E AU - Kovacs, E AU - Bereczky, Z AU - Balogh, L AU - Homorodi, N AU - Haramura, G TI - Development of reference methods for evaluating the effect of aspirin and for comparison with routinely used methods; the lack of aspirin resistance in healthy volunteers J2 - J Thromb Haemost PY - 2011 VL - 9 SP - 15 EP - 19 ER - TY - JOUR LB - 50. AU - Schwartz, KA AU - Schwartz, DE AU - Barber, K AU - Reeves, M AU - De Franco, AC TI - Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients J2 - J Transl Med PY - 2008 VL - 6 SP - 46 UR - http://dx.doi.org/10.1186/1479-5876-6-46 ER - TY - JOUR LB - 51. AU - Catella-Lawson, F AU - Reilly, MP AU - Kapoor, SC AU - Cucchiara, AJ AU - DeMarco, S AU - Tournier, B TI - Cyclooxygenase inhibitors and the antiplatelet effects of aspirin J2 - N Engl J Med PY - 2001 VL - 345 SP - 1809 EP - 1817 UR - http://dx.doi.org/10.1056/NEJMoa003199 ER - TY - JOUR LB - 52. AU - Capone, ML AU - Sciulli, MG AU - Tacconelli, S AU - Grana, M AU - Ricciotti, E AU - Renda, G TI - Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects J2 - J Am Coll Cardiol PY - 2005 VL - 45 SP - 1295 EP - 1301 UR - http://dx.doi.org/10.1016/j.jacc.2005.01.045 ER - TY - JOUR LB - 53. AU - Wilner, KD AU - Rushing, M AU - Walden, C AU - Adler, R AU - Eskra, J AU - Noveck, R TI - Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers J2 - J Clin Pharmacol PY - 2002 VL - 42 SP - 1027 EP - 1030 UR - http://dx.doi.org/10.1177/009127002401102858 ER - TY - JOUR LB - 54. AU - Van Ryn, J AU - Kink-Eiband, M AU - Kuritsch, I AU - Feifel, U AU - Hanft, G AU - Wallenstein, G TI - Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers J2 - J Clin Pharmacol PY - 2004 VL - 44 SP - 777 EP - 784 UR - http://dx.doi.org/10.1177/0091270004266623 ER - TY - JOUR LB - 55. AU - Maree, AO AU - Curtin, RJ AU - Dooley, M AU - Conroy, RM AU - Crean, P AU - Cox, D TI - Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease J2 - J Am Coll Cardiol PY - 2005 VL - 46 SP - 1258 EP - 1263 UR - http://dx.doi.org/10.1016/j.jacc.2005.06.058 ER - TY - JOUR LB - 56. AU - Angiolillo, DJ TI - Antiplatelet therapy in type 2 diabetes mellitus J2 - Curr Opin Endocrinol Diabetes Obes PY - 2007 VL - 14 SP - 124 EP - 131 UR - http://dx.doi.org/10.1097/MED.0b013e32807f2ad9 ER - TY - JOUR LB - 57. AU - Dichiara, J AU - Bliden, KP AU - Tantry, US AU - Hamed, MS AU - Antonino, MJ AU - Suarez, TA TI - The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study J2 - Diabetes PY - 2007 VL - 56 SP - 3014 EP - 3019 UR - http://dx.doi.org/10.2337/db07-0707 ER - TY - JOUR LB - 58. AU - Watala, C AU - Boncler, M AU - Gresner, P TI - Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus J2 - Pharmacol Rep PY - 2005 VL - 57 SP - 42 EP - 58 ER - TY - JOUR LB - 59. AU - Watala, C AU - Golanski, J AU - Pluta, J AU - Boncler, M AU - Rozalski, M AU - Luzak, B TI - Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin) – its relation to metabolic control J2 - Thromb Res PY - 2004 VL - 113 SP - 101 EP - 113 UR - http://dx.doi.org/10.1016/j.thromres.2003.12.016 ER - TY - JOUR LB - 60. AU - Pulcinelli, FM AU - Biasucci, LM AU - Riondino, S AU - Giubilato, S AU - Leo, A AU - Di Renzo, L TI - COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment J2 - Eur Heart J PY - 2009 VL - 30 SP - 1279 EP - 1286 UR - http://dx.doi.org/10.1093/eurheartj/ehp097 ER - TY - JOUR LB - 61. AU - Watala, C AU - Pluta, J AU - Golanski, J AU - Rozalski, M AU - Czyz, M AU - Trojanowski, Z TI - Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin J2 - J Mol Med (Berl) PY - 2005 VL - 83 SP - 148 EP - 158 UR - http://dx.doi.org/10.1007/s00109-004-0600-x ER - TY - JOUR LB - 62. AU - Kobzar, G AU - Mardla, V AU - Samel, N TI - Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors J2 - Platelets PY - 2011 VL - 22 SP - 338 EP - 344 UR - http://dx.doi.org/10.3109/09537104.2010.535931 ER - TY - JOUR LB - 63. AU - Pascale, S AU - Petrucci, G AU - Dragani, A AU - Habib, A AU - Zaccardi, F AU - Pagliaccia, F TI - Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target J2 - Blood PY - 2012 VL - 119 SP - 3595 EP - 3603 UR - http://dx.doi.org/10.1182/blood-2011-06-359224 ER - TY - JOUR LB - 64. AU - Dillinger, JG AU - Sideris, G AU - Henry, P AU - Bal dit Sollier, C AU - Ronez, E AU - Drouet, L TI - Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocythemia J2 - Thromb Res PY - 2012 VL - 129 SP - 91 EP - 94 UR - http://dx.doi.org/10.1016/j.thromres.2011.09.017 ER - TY - JOUR LB - 65. AU - Dragani, A AU - Pascale, S AU - Recchiuti, A AU - Mattoscio, D AU - Lattanzio, S AU - Petrucci, G TI - The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy J2 - Blood PY - 2010 VL - 115 SP - 1054 EP - 1061 UR - http://dx.doi.org/10.1182/blood-2009-08-236679 ER - TY - JOUR LB - 66. AU - Henry, P AU - Vermillet, A AU - Boval, B AU - Guyetand, C AU - Petroni, T AU - Dillinger, JG TI - 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease J2 - Thromb Haemost PY - 2011 VL - 105 SP - 336 EP - 344 UR - http://dx.doi.org/10.1160/TH10-02-0082 ER - TY - JOUR LB - 67. AU - Lordkipanidzé, M AU - Pharand, C AU - Schampaert, E AU - Palisaitis, DA AU - Diodati, JG TI - Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease J2 - Int J Cardiol PY - 2011 VL - 150 SP - 39 EP - 44 UR - http://dx.doi.org/10.1016/j.ijcard.2010.02.025 ER - TY - JOUR LB - 68. AU - Perneby, C AU - Wallen, NH AU - Rooney, C AU - Fitzgerald, D AU - Hjemdahl, P TI - Dose- and time-dependent antiplatelet effects of aspirin J2 - Thromb Haemost PY - 2006 VL - 95 SP - 652 EP - 658 ER - TY - JOUR LB - 69. AU - Di Minno, G TI - Aspirin resistance and platelet turnover: a 25-year old issue J2 - Nutr Metab Cardiovasc Dis PY - 2011 VL - 21 SP - 542 EP - 545 UR - http://dx.doi.org/10.1016/j.numecd.2011.04.002 ER - TY - JOUR LB - 70. AU - Grove, EL AU - Hvas, AM AU - Mortensen, SB AU - Larsen, SB AU - Kristensen, SD TI - Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease J2 - J Thromb Haemost PY - 2011 VL - 9 SP - 185 EP - 191 UR - http://dx.doi.org/10.1111/j.1538-7836.2010.04115.x ER - TY - JOUR LB - 71. AU - Capodanno, D AU - Patel, A AU - Dharmashankar, K AU - Ferreiro, JL AU - Ueno, M AU - Kodali, M TI - Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease J2 - Circ Cardiovasc Interv PY - 2011 VL - 4 SP - 180 EP - 187 UR - http://dx.doi.org/10.1161/CIRCINTERVENTIONS.110.960187 ER - TY - JOUR LB - 72. AU - Rocca, B AU - Santilli, F AU - Pitocco, D AU - Mucci, L AU - Petrucci, G AU - Vitacolonna, E TI - The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes J2 - J Thromb Haemost PY - 2012 VL - 10 SP - 1220 EP - 1230 UR - http://dx.doi.org/10.1111/j.1538-7836.2012.04723.x ER - TY - JOUR LB - 73. AU - Spectre, G AU - Arnetz, L AU - Ostenson, CG AU - Brismar, K AU - Li, N AU - Hjemdahl, P TI - Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications J2 - Thromb Haemost PY - 2011 VL - 106 SP - 491 EP - 499 UR - http://dx.doi.org/10.1160/TH11-04-0216 ER - TY - JOUR LB - 74. AU - Wurtz, M AU - Grove, EL TI - Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance J2 - Curr Pharm Des PY - 2012 VL - 18 SP - 5344 EP - 5361 UR - http://dx.doi.org/10.2174/138161212803251925 ER - TY - JOUR LB - 75. AU - Grove, EL AU - Hvas, AM AU - Johnsen, HL AU - Hedegaard, SS AU - Pedersen, SB AU - Mortensen, J TI - A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease J2 - Thromb Haemost PY - 2010 VL - 103 SP - 1245 EP - 1253 UR - http://dx.doi.org/10.1160/TH09-08-0527 ER - TY - JOUR LB - 76. AU - Frelinger, AL, III AU - Li, Y AU - Linden, MD AU - Barnard, MR AU - Fox, ML AU - Christie, DJ TI - Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization J2 - Circulation PY - 2009 VL - 120 SP - 2586 EP - 2596 UR - http://dx.doi.org/10.1161/CIRCULATIONAHA.109.900589 ER - TY - JOUR LB - 77. AU - Cattaneo, M TI - Laboratory detection of ‘aspirin resistance’: what test should we use (if any)? J2 - Eur Heart J PY - 2007 VL - 28 SP - 1673 EP - 1675 UR - http://dx.doi.org/10.1093/eurheartj/ehm232 ER - TY - JOUR LB - 78. AU - Raichand, S AU - Moore, D AU - Riley, R AU - Lordkipanidzé, M AU - Dretzke, J AU - O’Donnell, J TI - Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease J2 - Syst Rev PY - 2013 VL - 2 SP - 16 UR - http://dx.doi.org/10.1186/2046-4053-2-16 ER - TY - JOUR LB - 79. AU - Whiting, PF AU - Rutjes, AWS AU - Westwood, ME AU - Mallett, S AU - Deeks, JJ AU - Reitsma, JB TI - QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies J2 - Ann Intern Med PY - 2011 VL - 155 SP - 529 EP - 536 UR - http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009 ER - TY - JOUR LB - 80. AU - Hayden, JA AU - Cote, P AU - Bombardier, C TI - Evaluation of the quality of prognosis studies in systematic reviews J2 - Ann Intern Med PY - 2006 VL - 144 SP - 427 EP - 437 UR - http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00010 ER - TY - JOUR LB - 81. AU - Altman, DG TI - Prognostic models: a methodological framework and review of models for breast cancer J2 - Cancer Invest PY - 2009 VL - 27 SP - 235 EP - 243 UR - http://dx.doi.org/10.1080/07357900802572110 ER - TY - JOUR LB - 82. AU - Parmar, MKB AU - Torri, V AU - Stewart, L TI - Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints J2 - Stat Med PY - 1998 VL - 17 SP - 2815 EP - 2834 UR - http://dx.doi.org/10.1002/(SICI)1097-0258(19981230)17:24%3C2815::AID-SIM110%3E3.0.CO;2-8 ER - TY - JOUR LB - 83. AU - Perneger, TV TI - Estimating the relative hazard by the ratio of logarithms of event-free proportions J2 - Contemp Clin Trials PY - 2008 VL - 29 SP - 762 EP - 766 UR - http://dx.doi.org/10.1016/j.cct.2008.06.002 ER - TY - JOUR LB - 84. AU - Sweeting, MJ AU - Sutton, AJ AU - Lambert, PC TI - What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data J2 - Stat Med PY - 2004 VL - 23 SP - 1351 EP - 1375 UR - http://dx.doi.org/10.1002/sim.1761 ER - TY - JOUR LB - 85. AU - Kip, KE AU - Hollabaugh, K AU - Marroquin, OC AU - Williams, DO TI - The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention J2 - J Am Coll Cardiol PY - 2008 VL - 51 SP - 701 EP - 707 UR - http://dx.doi.org/10.1016/j.jacc.2007.10.034 ER - TY - JOUR LB - 86. AU - Ozben, S AU - Ozben, B AU - Tanrikulu, AM AU - Ozer, F AU - Ozben, T TI - Aspirin resistance in patients with acute ischemic stroke J2 - J Neurol PY - 2011 VL - 258 SP - 1979 EP - 1986 UR - http://dx.doi.org/10.1007/s00415-011-6052-7 ER - TY - JOUR LB - 87. AU - Lee, SP AU - Park, KW AU - Shin, DH AU - Lee, HY AU - Kang, HJ AU - Koo, BK TI - Efficacy of predicting thrombotic events with combination of dual point-of-care testing (POCT) after drug-eluting stent implantation for coronary heart disease: results from the CILON-T randomized trial POCT substudy J2 - J Atheroscler Thromb PY - 2011 VL - 18 SP - 914 EP - 923 UR - http://dx.doi.org/10.5551/jat.9290 ER - TY - JOUR LB - 88. AU - Feher, A AU - Pusch, G AU - Harang, G AU - Gasztonyi, B AU - Papp, E AU - Werling, D TI - Aspirin resistance in cerebrovascular patients J2 - Int J Cardiol PY - 2011 VL - 152 SP - 111 EP - 112 UR - http://dx.doi.org/10.1016/j.ijcard.2011.07.028 ER - TY - JOUR LB - 89. AU - Chiu, FC AU - Wang, TD AU - Lee, JK AU - Shih, FY AU - Lin, JW AU - Huang, CH TI - Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention J2 - Eur J Intern Med PY - 2011 VL - 22 SP - 471 EP - 477 UR - http://dx.doi.org/10.1016/j.ejim.2011.02.021 ER - TY - JOUR LB - 90. AU - van der Loo, B AU - Braun, J AU - Koppensteiner, R TI - On-treatment function testing of platelets and long-term outcome of patients with peripheral arterial disease undergoing transluminal angioplasty J2 - Eur J Vasc Endovasc Surg PY - 2011 VL - 42 SP - 809 EP - 816 UR - http://dx.doi.org/10.1016/j.ejvs.2011.08.014 ER - TY - JOUR LB - 91. AU - Amoah, V AU - Smallwood, A AU - Worrall, AP AU - Lovatt, T AU - Armesilla, AL AU - Nevill, AM TI - Poor aspirin response in diabetic patients presenting with acute coronary syndromes: results using a near patient test J2 - Thromb Res PY - 2011 VL - 128 SP - 196 EP - 199 UR - http://dx.doi.org/10.1016/j.thromres.2011.04.003 ER - TY - JOUR LB - 92. AU - Kim, HJ AU - Lee, JM AU - Seo, JH AU - Kim, JH AU - Hong, DM AU - Bahk, JH TI - Preoperative aspirin resistance does not increase myocardial injury during off-pump coronary artery bypass surgery J2 - J Korean Med Sci PY - 2011 VL - 26 SP - 1041 EP - 1046 UR - http://dx.doi.org/10.3346/jkms.2011.26.8.1041 ER - TY - JOUR LB - 93. AU - Spectre, G AU - Mosseri, M AU - Abdelrahman, NM AU - Briskin, E AU - Bulut, A AU - Loncar, S TI - Clinical and prognostic implications of the initial response to aspirin in patients with acute coronary syndrome J2 - Am J Cardiol PY - 2011 VL - 108 SP - 1112 EP - 1118 UR - http://dx.doi.org/10.1016/j.amjcard.2011.06.013 ER - TY - JOUR LB - 94. AU - Grdinic, A AU - Vojvodic, D AU - Djukanovic, N AU - Colic, M AU - Grdinic, AG AU - Ignjatovic, V TI - PCI and clopidogrel: antiplatelet responsiveness and patient characteristics J2 - Acta Cardiol PY - 2011 VL - 66 SP - 333 EP - 340 ER - TY - JOUR LB - 95. AU - Abumiya, T AU - Houkin, K TI - Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin J2 - J Stroke Cerebrovasc Dis PY - 2011 VL - 20 SP - 319 EP - 323 UR - http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2010.01.013 ER - TY - JOUR LB - 96. AU - Angiolillo, DJ AU - Bernardo, E AU - Zanoni, M AU - Vivas, D AU - Capranzano, P AU - Malerba, G TI - Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease J2 - J Am Coll Cardiol PY - 2011 VL - 58 SP - 30 EP - 39 UR - http://dx.doi.org/10.1016/j.jacc.2011.02.040 ER - TY - JOUR LB - 97. AU - Kuliczkowski, W AU - Greif, M AU - Gasior, M AU - Kaczmarski, J AU - Pres, D AU - Polonski, L TI - Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention J2 - Kardiol Pol PY - 2011 VL - 69 SP - 531 EP - 537 ER - TY - JOUR LB - 98. AU - Breet, NJ AU - van Werkum, JW AU - Bouman, HJ AU - Kelder, JC AU - Harmsze, AM AU - Hackeng, CM TI - High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention J2 - Heart PY - 2011 VL - 97 SP - 983 EP - 990 UR - http://dx.doi.org/10.1136/hrt.2010.220491 ER - TY - JOUR LB - 99. AU - Gluckman, TJ AU - McLean, RC AU - Schulman, SP AU - Kickler, TS AU - Shapiro, EP AU - Conte, JV TI - Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery J2 - J Am Coll Cardiol PY - 2011 VL - 57 SP - 1069 EP - 1077 UR - http://dx.doi.org/10.1016/j.jacc.2010.08.650 ER - TY - JOUR LB - 100. AU - Ko, YG AU - Suh, JW AU - Kim, BH AU - Lee, CJ AU - Kim, JS AU - Choi, D TI - Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention J2 - Am Heart J PY - 2011 VL - 161 SP - 383 EP - 390 UR - http://dx.doi.org/10.1016/j.ahj.2010.10.036 ER - TY - JOUR LB - 101. AU - Breet, NJ AU - van Werkum, JW AU - Bouman, HJ AU - Kelder, JC AU - ten Berg, JM AU - Hackeng, CM TI - High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events J2 - J Thromb Haemost PY - 2010 VL - 8 SP - 2140 EP - 2148 UR - http://dx.doi.org/10.1111/j.1538-7836.2010.04017.x ER - TY - JOUR LB - 102. AU - Smit, JJ AU - van Werkum, JW AU - ten Berg, J AU - Slingerland, R AU - Ottervanger, JP AU - Heestermans, T TI - Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy J2 - Heart PY - 2010 VL - 96 SP - 1815 EP - 1820 UR - http://dx.doi.org/10.1136/hrt.2010.201889 ER - TY - JOUR LB - 103. AU - Campo, G AU - Fileti, L AU - de Cesare, N AU - Meliga, E AU - Furgieri, A AU - Russo, F TI - Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy J2 - J Am Coll Cardiol PY - 2010 VL - 56 SP - 1447 EP - 1455 UR - http://dx.doi.org/10.1016/j.jacc.2010.03.103 ER - TY - JOUR LB - 104. AU - Marcucci, R AU - Gori, AM AU - Paniccia, R AU - Giusti, B AU - Valente, S AU - Giglioli, C TI - High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting J2 - Thromb Haemost PY - 2010 VL - 104 SP - 279 EP - 286 UR - http://dx.doi.org/10.1160/TH10-01-0007 ER - TY - JOUR LB - 105. AU - Chu, JW AU - Wong, CK AU - Chambers, J AU - Wout, JV AU - Herbison, P AU - Tang, EW TI - Aspirin resistance determined from a bed-side test in patients suspected to have acute coronary syndrome portends a worse 6 months outcome J2 - QJM PY - 2010 VL - 103 SP - 405 EP - 412 UR - http://dx.doi.org/10.1093/qjmed/hcq038 ER - TY - JOUR LB - 106. AU - Eshtehardi, P AU - Windecker, S AU - Cook, S AU - Billinger, M AU - Togni, M AU - Garachemani, A TI - Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation J2 - Am Heart J PY - 2010 VL - 159 SP - 891 EP - 898 UR - http://dx.doi.org/10.1016/j.ahj.2010.02.025 ER - TY - JOUR LB - 107. AU - Campo, G AU - Valgimigli, M AU - Frangione, A AU - Luccarelli, S AU - Cangiano, E AU - Cavazza, C TI - Evaluation of platelet inhibition by tirofiban in patients stratified according to aspirin and clopidogrel responsiveness: the 3T/2R (Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) J2 - J Am Coll Cardiol PY - 2010 VL - 55 SP - 255 EP - 256 UR - http://dx.doi.org/10.1016/j.jacc.2009.08.052 ER - TY - JOUR LB - 108. AU - Addad, F AU - Chakroun, T AU - Abderazek, F AU - Ben-Farhat, M AU - Hamdi, S AU - Dridi, Z TI - Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease J2 - J Thromb Thrombolysis PY - 2010 VL - 29 SP - 108 EP - 113 UR - http://dx.doi.org/10.1007/s11239-009-0335-1 ER - TY - JOUR LB - 109. AU - Aksu, H AU - Ozer, O AU - Unal, H AU - Hobikoglu, G AU - Norgaz, T AU - Buturak, A TI - Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes J2 - Blood Coagul Fibrinolysis PY - 2009 VL - 20 SP - 686 EP - 693 UR - http://dx.doi.org/10.1097/MBC.0b013e32833161ac ER - TY - JOUR LB - 110. AU - Thomson, VS AU - John, B AU - George, P AU - Joseph, G AU - Jose, J TI - Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events J2 - J Postgrad Med PY - 2009 VL - 55 SP - 252 EP - 256 UR - http://dx.doi.org/10.4103/0022-3859.58927 ER - TY - JOUR LB - 111. AU - Cuisset, T AU - Cayla, G AU - Frere, C AU - Quilici, J AU - Poyet, R AU - Gaborit, B TI - Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment? J2 - Eurointervention PY - 2009 VL - 5 SP - 325 EP - 329 UR - http://dx.doi.org/10.4244/51 ER - TY - JOUR LB - 112. AU - Linnemann, B AU - Prochnow, S AU - Mani, H AU - Schwonberg, J AU - Lindhoff-Last, E TI - Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up J2 - Ann Hematol PY - 2009 VL - 88 SP - 979 EP - 988 UR - http://dx.doi.org/10.1007/s00277-009-0708-8 ER - TY - JOUR LB - 113. AU - Kempfert, J AU - Anger, K AU - Rastan, A AU - Krabbes, S AU - Lehmann, S AU - Garbade, J TI - Postoperative development of aspirin resistance following coronary artery bypass J2 - Eur J Clin Invest PY - 2009 VL - 39 SP - 769 EP - 774 UR - http://dx.doi.org/10.1111/j.1365-2362.2009.02175.x ER - TY - JOUR LB - 114. AU - Ivandic, BT AU - Sausemuth, M AU - Ibrahim, H AU - Giannitsis, E AU - Gawaz, M AU - Katus, HA TI - Dual antiplatelet drug resistance is a risk factor for cardiovascular events after percutaneous coronary intervention J2 - Clin Chem PY - 2009 VL - 55 SP - 1171 EP - 1176 UR - http://dx.doi.org/10.1373/clinchem.2008.115089 ER - TY - JOUR LB - 115. AU - Foussas, SG AU - Zairis, MN AU - Tsirimpis, VG AU - Makrygiannis, SS AU - Patsourakos, NG AU - Adamopoulou, EN TI - The impact of aspirin resistance on the long-term cardiovascular mortality in patients with non-ST segment elevation acute coronary syndromes J2 - Clin Cardiol PY - 2009 VL - 32 SP - 142 EP - 147 UR - http://dx.doi.org/10.1002/clc.20293 ER - TY - JOUR LB - 116. AU - Boncoraglio, GB AU - Bodini, A AU - Brambilla, C AU - Corsini, E AU - Carriero, MR AU - Parati, EA TI - Aspirin resistance determined with PFA-100 does not predict new thrombotic events in patients with stable ischemic cerebrovascular disease J2 - Clin Neurol Neurosurg PY - 2009 VL - 111 SP - 270 EP - 273 UR - http://dx.doi.org/10.1016/j.clineuro.2008.11.001 ER - TY - JOUR LB - 117. AU - Majeed, F AU - Kop, WJ AU - Poston, RS AU - Kallam, S AU - Mehra, MR TI - Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices J2 - Nat Clin Pract Cardiovasc Med PY - 2009 VL - 6 SP - 147 EP - 157 UR - http://dx.doi.org/10.1038/ncpcardio1441 ER - TY - JOUR LB - 118. AU - Bevilacqua, S AU - Alkodami, AA AU - Volpi, E AU - Cerillo, AG AU - Berti, S AU - Glauber, M TI - Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function J2 - Ann Thorac Surg PY - 2009 VL - 87 SP - 496 EP - 502 UR - http://dx.doi.org/10.1016/j.athoracsur.2008.05.038 ER - TY - JOUR LB - 119. AU - Saw, J AU - Densem, C AU - Walsh, S AU - Jokhi, P AU - Starovoytov, A AU - Fox, R TI - The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy J2 - JACC Cardiovasc Interv PY - 2008 VL - 1 SP - 654 EP - 659 UR - http://dx.doi.org/10.1016/j.jcin.2008.08.017 ER - TY - JOUR LB - 120. AU - Gori, AM AU - Marcucci, R AU - Paniccia, R AU - Giusti, B AU - Fedi, S AU - Antonucci, E TI - Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function J2 - Thromb Haemost PY - 2008 VL - 100 SP - 1136 EP - 1145 ER - TY - JOUR LB - 121. AU - Cha, JK AU - Jeon, HW AU - Kang, MJ TI - ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy J2 - Eur J Neurol PY - 2008 VL - 15 SP - 1304 EP - 1308 UR - http://dx.doi.org/10.1111/j.1468-1331.2008.02306.x ER - TY - JOUR LB - 122. AU - Gurbel, PA AU - Antonino, MJ AU - Bliden, KP AU - Dichiara, J AU - Suarez, TA AU - Singla, A TI - Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target J2 - Platelets PY - 2008 VL - 19 SP - 595 EP - 604 UR - http://dx.doi.org/10.1080/09537100802351065 ER - TY - JOUR LB - 123. AU - Campo, G AU - Valgimigli, M AU - Frangione, A AU - Tebaldi, M AU - Ferrari, R TI - Prognostic value of serial platelet reactivity measurements on long-term clinical outcome in patients with ST-elevation myocardial infarction undergoing primary PCI J2 - J Thromb Haemost PY - 2008 VL - 6 SP - 1824 EP - 1826 UR - http://dx.doi.org/10.1111/j.1538-7836.2008.03112.x ER - TY - JOUR LB - 124. AU - Gori, AM AU - Marcucci, R AU - Migliorini, A AU - Valenti, R AU - Moschi, G AU - Paniccia, R TI - Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents J2 - J Am Coll Cardiol PY - 2008 VL - 52 SP - 734 EP - 739 UR - http://dx.doi.org/10.1016/j.jacc.2008.05.032 ER - TY - JOUR LB - 125. AU - Schwammenthal, Y AU - Tsabari, R AU - Shenkman, B AU - Schwartz, R AU - Matetzky, S AU - Lubetsky, A TI - Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome J2 - Cerebrovasc Dis PY - 2008 VL - 25 SP - 355 EP - 361 UR - http://dx.doi.org/10.1159/000118382 ER - TY - JOUR LB - 126. AU - Aradi, D AU - Konyi, A AU - Palinkas, L AU - Berki, T AU - Pinter, T AU - Tahin, T TI - Thienopyridine therapy influences late outcome after coronary stent implantation J2 - Angiology PY - 2008 VL - 59 SP - 172 EP - 178 UR - http://dx.doi.org/10.1177/0003319707304572 ER - TY - JOUR LB - 127. AU - Christiaens, L AU - Ragot, S AU - Mergy, J AU - Allal, J AU - Macchi, L TI - Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study J2 - Blood Coagul Fibrinolysis PY - 2008 VL - 19 SP - 235 EP - 239 UR - http://dx.doi.org/10.1097/MBC.0b013e3282f9ade8 ER - TY - JOUR LB - 128. AU - Gengo, FM AU - Rainka, M AU - Robson, M AU - Gengo, MF AU - Forrest, A AU - Hourihane, M TI - Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events J2 - J Clin Pharmacol PY - 2008 VL - 48 SP - 335 EP - 343 UR - http://dx.doi.org/10.1177/0091270007313324 ER - TY - JOUR LB - 129. AU - Jacopo, G AU - Elisabetta, V AU - Silverio, S AU - Massimiliano, M AU - Sergio, B AU - Grazia, AM TI - Identification of platelet hyper-reactivity measured with a portable device immediately after percutaneous coronary intervention predicts in stent thrombosis J2 - Thromb Res PY - 2007 VL - 121 SP - 407 EP - 412 UR - http://dx.doi.org/10.1016/j.thromres.2007.04.009 ER - TY - JOUR LB - 130. AU - Blindt, R AU - Stellbrink, K AU - de Taeye, A AU - Muller, R AU - Kiefer, P AU - Yagmur, E TI - The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis J2 - Thromb Haemost PY - 2007 VL - 98 SP - 1329 EP - 1334 ER - TY - JOUR LB - 131. AU - Foussas, SG AU - Zairis, MN AU - Patsourakos, NG AU - Makrygiannis, SS AU - Adamopoulou, EN AU - Handanis, SM TI - The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting J2 - Am Heart J PY - 2007 VL - 154 SP - 676 EP - 681 UR - http://dx.doi.org/10.1016/j.ahj.2007.06.013 ER - TY - JOUR LB - 132. AU - Poulsen, TS AU - Kristensen, SR AU - Korsholm, L AU - Haghfelt, T AU - Jorgensen, B AU - Licht, PB TI - Variation and importance of aspirin resistance in patients with known cardiovascular disease J2 - Thromb Res PY - 2007 VL - 120 SP - 477 EP - 484 UR - http://dx.doi.org/10.1016/j.thromres.2006.10.022 ER - TY - JOUR LB - 133. AU - Chen, WH AU - Cheng, X AU - Lee, PY AU - Ng, W AU - Kwok, JY AU - Tse, HF TI - Aspirin resistance and adverse clinical events in patients with coronary artery disease J2 - Am J Med PY - 2007 VL - 120 SP - 631 EP - 635 UR - http://dx.doi.org/10.1016/j.amjmed.2006.10.021 ER - TY - JOUR LB - 134. AU - Buch, AN AU - Singh, S AU - Roy, P AU - Javaid, A AU - Smith, KA AU - George, CE TI - Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention J2 - Am J Cardiol PY - 2007 VL - 99 SP - 1518 EP - 1522 UR - http://dx.doi.org/10.1016/j.amjcard.2007.01.023 ER - TY - JOUR LB - 135. AU - Hobikoglu, GF AU - Norgaz, T AU - Aksu, H AU - Ozer, O AU - Erturk, M AU - Destegul, E TI - The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy J2 - Can J Cardiol PY - 2007 VL - 23 SP - 201 EP - 206 UR - http://dx.doi.org/10.1016/S0828-282X(07)70744-4 ER - TY - JOUR LB - 136. AU - Bliden, KP AU - Dichiara, J AU - Tantry, US AU - Bassi, AK AU - Chaganti, SK AU - Gurbel, PA TI - Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J2 - J Am Coll Cardiol PY - 2007 VL - 49 SP - 657 EP - 666 UR - http://dx.doi.org/10.1016/j.jacc.2006.10.050 ER - TY - JOUR LB - 137. AU - Pamukcu, B AU - Oflaz, H AU - Onur, I AU - Oncul, A AU - Ozcan, M AU - Umman, B TI - Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR) J2 - Blood Coagul Fibrinolysis PY - 2007 VL - 18 SP - 187 EP - 192 UR - http://dx.doi.org/10.1097/MBC.0b013e328040c115 ER - TY - JOUR LB - 138. AU - Fuchs, I AU - Frossard, M AU - Spiel, A AU - Riedmuller, E AU - Laggner, AN AU - Jilma, B TI - Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS J2 - J Thromb Haemost PY - 2006 VL - 4 SP - 2547 EP - 2552 UR - http://dx.doi.org/10.1111/j.1538-7836.2006.02239.x ER - TY - JOUR LB - 139. AU - Marcucci, R AU - Paniccia, R AU - Antonucci, E AU - Gori, AM AU - Fedi, S AU - Giglioli, C TI - Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events J2 - Am J Cardiol PY - 2006 VL - 98 SP - 1156 EP - 1159 UR - http://dx.doi.org/10.1016/j.amjcard.2006.05.041 ER - TY - JOUR LB - 140. AU - Pamukcu, B AU - Oflaz, H AU - Oncul, A AU - Umman, B AU - Mercanoglu, F AU - Ozcan, M TI - The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events J2 - J Thromb Thrombolysis PY - 2006 VL - 22 SP - 103 EP - 110 UR - http://dx.doi.org/10.1007/s11239-006-8952-4 ER - TY - JOUR LB - 141. AU - Gianetti, J AU - Parri, MS AU - Sbrana, S AU - Paoli, F AU - Maffei, S AU - Paradossi, U TI - Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study J2 - Thromb Res PY - 2006 VL - 118 SP - 487 EP - 493 UR - http://dx.doi.org/10.1016/j.thromres.2005.10.011 ER - TY - JOUR LB - 142. AU - Ohmori, T AU - Yatomi, Y AU - Nonaka, T AU - Kobayashi, Y AU - Madoiwa, S AU - Mimuro, J TI - Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients J2 - J Thromb Haemost PY - 2006 VL - 4 SP - 1271 EP - 1278 UR - http://dx.doi.org/10.1111/j.1538-7836.2006.01958.x ER - TY - JOUR LB - 143. AU - Cuisset, T AU - Frere, C AU - Quilici, J AU - Barbou, F AU - Morange, PE AU - Hovasse, T TI - High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome J2 - J Thromb Haemost PY - 2006 VL - 4 SP - 542 EP - 549 UR - http://dx.doi.org/10.1111/j.1538-7836.2005.01751.x ER - TY - JOUR LB - 144. AU - Morawski, W AU - Sanak, M AU - Cisowski, M AU - Szczeklik, M AU - Szczeklik, W AU - Dropinski, J TI - Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism J2 - J Thorac Cardiovasc Surg PY - 2005 VL - 130 SP - 791 EP - 796 UR - http://dx.doi.org/10.1016/j.jtcvs.2005.02.041 ER - TY - JOUR LB - 145. AU - Sambola, A AU - Heras, M AU - Escolar, G AU - Lozano, M AU - Pino, M AU - Martorell, T TI - The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin J2 - Platelets PY - 2004 VL - 15 SP - 439 EP - 446 UR - http://dx.doi.org/10.1080/69537100412351272550 ER - TY - JOUR LB - 146. AU - Stejskal, D AU - Proskova, J AU - Lacnak, B AU - Horalik, D AU - Hamplova, A AU - Oral, I TI - Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications J2 - Vnitr Lek PY - 2004 VL - 50 SP - 591 EP - 599 ER - TY - JOUR LB - 147. AU - Payne, DA AU - Jones, CI AU - Hayes, PD AU - Thompson, MM AU - London, NJ AU - Bell, PR TI - Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy J2 - Circulation PY - 2004 VL - 109 SP - 1476 EP - 1481 UR - http://dx.doi.org/10.1161/01.CIR.0000121739.05643.E6 ER - TY - JOUR LB - 148. AU - Bruno, A AU - McConnell, JP AU - Cohen, SN AU - Tietjen, GE AU - Wallis, RA AU - Gorelick, PB TI - Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction J2 - Stroke PY - 2004 VL - 35 SP - 727 EP - 730 UR - http://dx.doi.org/10.1161/01.STR.0000117097.76953.A6 ER - TY - JOUR LB - 149. AU - Gum, PA AU - Kottke-Marchant, K AU - Welsh, PA AU - White, J AU - Topol, EJ TI - A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J2 - J Am Coll Cardiol PY - 2003 VL - 41 SP - 961 EP - 965 UR - http://dx.doi.org/10.1016/S0735-1097(02)03014-0 ER - TY - JOUR LB - 150. AU - Ziegler, S AU - Maca, T AU - Alt, E AU - Speiser, W AU - Schneider, B AU - Minar, E TI - Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients J2 - Platelets PY - 2002 VL - 13 SP - 493 EP - 497 UR - http://dx.doi.org/10.1080/0953710021000057866 ER - TY - JOUR LB - 151. AU - Eikelboom, JW AU - Hirsh, J AU - Weitz, JI AU - Johnston, M AU - Yi, Q AU - Yusuf, S TI - Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events J2 - Circulation PY - 2002 VL - 105 SP - 1650 EP - 1655 UR - http://dx.doi.org/10.1161/01.CIR.0000013777.21160.07 ER - TY - JOUR LB - 152. AU - Buchanan, MR AU - Schwartz, L AU - Bourassa, M AU - Brister, SJ AU - Peniston, CM AU - BRAT Investigators TI - Results of the BRAT study – a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery J2 - Can J Cardiol PY - 2000 VL - 16 SP - 1385 EP - 1390 ER - TY - JOUR LB - 153. AU - Mueller, MR AU - Salat, A AU - Stangl, P AU - Murabito, M AU - Pulaki, S AU - Boehm, D TI - Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty J2 - Thromb Haemost PY - 1997 VL - 78 SP - 1003 EP - 1007 ER - TY - JOUR LB - 154. AU - Grotemeyer, KH AU - Scharafinski, HW AU - Husstedt, IW TI - Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients J2 - Thromb Res PY - 1993 VL - 71 SP - 397 EP - 403 UR - http://dx.doi.org/10.1016/0049-3848(93)90164-J ER - TY - JOUR LB - 155. AU - Sørensen, PS AU - Agerskov, AL AU - Gormsen, J AU - Pedersen, H AU - Marquardsen, J AU - Petersson, H TI - Prognostic value of in vitro measurements of platelet aggregability and fibrinolytic activity in patients with reversible cerebral ischemic attacks J2 - Eur Neurol PY - 1983 VL - 22 SP - 437 EP - 441 UR - http://dx.doi.org/10.1159/000115599 ER - TY - JOUR LB - 156. AU - Tang, FK AU - Lin, LJ AU - Hua, N AU - Lu, H AU - Qi, Z AU - Tang, XZ TI - Earlier application of loading doses of aspirin and clopidogrel decreases rate of recurrent cardiovascular ischemic events for patients undergoing percutaneous coronary intervention J2 - Chin Med J PY - 2012 VL - 125 SP - 631 EP - 638 ER - TY - JOUR LB - 157. AU - Breet, NJ AU - Sluman, MA AU - van Berkel, MAJP AU - van Werkum, JW AU - Bouman, HJ AU - Harmsze, AM TI - Effect of gender difference on platelet reactivity J2 - Neth Heart J PY - 2011 VL - 19 SP - 451 EP - 457 UR - http://dx.doi.org/10.1007/s12471-011-0189-y ER - TY - JOUR LB - 158. AU - Milicic, D AU - Lovric, D AU - Skoric, B AU - Narancic-Skoric, K AU - Gornik, I AU - Sertic, J TI - Platelet response to standard aspirin and clopidogrel treatment correlates with long-term outcome in patients with acute ST-elevation myocardial infarction J2 - Int J Cardiol PY - 2011 VL - 153 SP - 227 EP - 229 UR - http://dx.doi.org/10.1016/j.ijcard.2011.09.055 ER - TY - JOUR LB - 159. AU - De Boni, A AU - De Riva, V AU - Galloni, E AU - Perini, F TI - Residual platelet activity and clinical failure of antithrombotic prophylaxis in acute cerebral ischaemic stroke J2 - Riv Ital Med Labor PY - 2011 VL - 7 SP - 163 EP - 169 UR - http://dx.doi.org/10.1007/s13631-011-0024-8 ER - TY - JOUR LB - 160. AU - Marcucci, R AU - Gori, AM AU - Paniccia, R AU - Giusti, B AU - Cordisco, A AU - Balzi, D TI - High-on treatment platelet reactivity by different stimuli is a determinant of 1 year mortality in acute coronary syndrome patients: Data from AMI-florence 2 study J2 - J Thromb Haemost PY - 2011 VL - 9 SP - 546 EP - 547 ER - TY - JOUR LB - 161. AU - Marcucci, R AU - Gori, AM AU - Paniccia, R AU - Giusti, B AU - Cordisco, A AU - Balzi, D TI - High-on clopidogrel platelet reactivity is a determinant of 1-year mortality in acute coronary syndrome patients: Data from AMI-florence 2 study J2 - J Thromb Haemost PY - 2011 VL - 9 SP - 546 ER - TY - JOUR LB - 162. AU - Lordkipanidzé, M AU - Diodati, JG AU - Schampaert, E AU - Palisaitis, DA AU - Pharand, C TI - Lack of clinical predictiveness of six major platelet function tests used to assess aspirin response in patients with stable coronary artery disease J2 - J Thromb Haemost PY - 2011 VL - 9 SP - 343 ER - TY - JOUR LB - 163. AU - Spectre, G AU - Mosseri, M AU - Abdelrahman, NM AU - Briskin, E AU - Bulut, A AU - Loncar, S TI - Dynamic response to aspirin in patients with acute coronary syndrome, clinical and prognostic implications J2 - J Thromb Haemost PY - 2011 VL - 9 SP - 338 UR - http://dx.doi.org/10.1016/j.amjcard.2011.06.013 ER - TY - JOUR LB - 164. AU - Miyata, S AU - Kada, A AU - Nagatsuka, K TI - Clinical impact of aspirin ‘resistance’ on the secondary prevention of atherothrombosis J2 - J Thromb Haemost PY - 2011 VL - 9 SP - 257 ER - TY - JOUR LB - 165. AU - Kaymaz, C AU - Tokgoz, HC AU - Tanboga, IH AU - Poci, N AU - Aktemur, T AU - Kirca, N TI - Can we translate the high and low on-treatment platelet reactivity to early, mid and long term risks for ischemic and bleeding events following the stent placement J2 - Eur Heart J PY - 2011 VL - 32 SP - 755 ER - TY - JOUR LB - 166. AU - Orta, KK AU - Kocas, C AU - Yildiz, A AU - Abaci, O AU - Okcun, B AU - Coskun, U TI - Long-term follow-up of the patients with Aspirin resistant end stage kidney disease J2 - Eur Heart J PY - 2011 VL - 32 SP - 322 EP - 323 ER - TY - JOUR LB - 167. AU - Kaymaz, C AU - Tanboga, IH AU - Tokgoz, HC AU - Can, MM AU - Poci, N AU - Aktemur, T TI - Comparison of multiplate, VerifyNow and PFA-100 in the assessment of on-treatment platelet reactivity in patients treated with aspirin and clopidogrel following coronary stenting J2 - Eur Heart J PY - 2011 VL - 32 SP - 246 ER - TY - JOUR LB - 168. AU - Sahin, DY AU - Koc, M AU - Cayli, M AU - Sen, O AU - Kalkan, GY AU - Kanadasi, M TI - Frequency of aspirin resistance in patients with chronic ischemic heart disease in Cukurova region and the relationship between aspirin resistance and adverse clinical events J2 - Int J Cardiol PY - 2011 VL - 147 SP - S157 UR - http://dx.doi.org/10.1016/S0167-5273(11)70427-2 ER - TY - JOUR LB - 169. AU - Zanow, J AU - Eckart, A AU - Ludewig, S AU - Losche, W TI - Frequency and clinical significance of the ‘non-response’ to acetylsalicylic acid in patients with peripheral occlusive artery disease J2 - Vasomed PY - 2010 VL - 22 SP - 277 ER - TY - JOUR LB - 170. AU - Ryu, D-S AU - Hong, C-K AU - Sim, Y-S AU - Kim, C-H AU - Jung, J-Y AU - Joo, J-Y TI - Anti-platelet drug resistance in the prediction of thromboembolic complications after neurointervention J2 - J Korean Neurosurg Soc PY - 2010 VL - 48 SP - 319 EP - 324 UR - http://dx.doi.org/10.3340/jkns.2010.48.4.319 ER - TY - JOUR LB - 171. AU - Lee, J-H AU - Cha, J-K AU - Lee, SJ AU - Ha, S-W AU - Kwon, SU TI - Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial J2 - Eur J Neurol PY - 2010 VL - 17 SP - 434 EP - 442 UR - http://dx.doi.org/10.1111/j.1468-1331.2009.02837.x ER - TY - JOUR LB - 172. AU - Angiolillo, D AU - Bernardo, E AU - Zanoni, M AU - Capranzano, P AU - Malerba, G AU - Trabetti, E TI - Impact of IRS-1 genotypes on platelet reactivity and cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease J2 - J Am Coll Cardiol PY - 2010 VL - 55 IS - Suppl. 1 SP - A207 UR - http://dx.doi.org/10.1016/j.jacc.2011.02.040 ER - TY - JOUR LB - 173. AU - Bouman, HJ AU - van Werkum, JW AU - Smit, JJ AU - Breet, NJ AU - Postma, S AU - Heestermans, T TI - Predictive value of various platelet function tests on ST-segment resolution and clinical outcome in stemi patients randomized to either dual or triple antiplatelet therapy: the onTIME2 platelet function substudy J2 - J Am Coll Cardiol PY - 2010 VL - 55 IS - Suppl. 1 SP - A207 UR - http://dx.doi.org/10.1016/S0735-1097(10)61949-3 ER - TY - JOUR LB - 174. AU - Tan, C AU - Lin, J AU - Chen, W AU - Lin, R AU - Chen, S TI - Elevated serum ubiquitin and ubiquitin conjugates: A potential biomarker for aspirin resistance in acute myocardial infarction patients J2 - Arterioscler Thromb Vasc Biol PY - 2010 VL - 30 SP - e219 EP - e220 ER - TY - JOUR LB - 175. AU - Toth, G AU - Pride, GL AU - Novakovic, R AU - Matevosyan, K AU - Sarode, R AU - Welch, BG TI - Thromboembolic complications and response to antiplatelet therapy in patients undergoing endovascular stenting for aneurysm treatment J2 - Stroke PY - 2010 VL - 41 SP - e265 EP - e266 ER - TY - JOUR LB - 176. AU - Bobesc, E AU - Rado, M AU - Datc, G AU - Dobrean, D AU - Dok, BF TI - The effects of endothelial dysfunction, platelets hyperactivity, oxidative stress biomarkers on ejection fraction, wall motion score index and prognosis in patients with acute coronary syndromes J2 - Eur J Echocardiogr PY - 2010 VL - 11 SP - ii122 EP - ii123 ER - TY - JOUR LB - 177. AU - Bobescu, E AU - Radoi, M AU - Datcu, G AU - Dobreanu, D AU - Doka, B TI - Correlation between endothelial dysfunction, platelets hyperactivity, oxidative stress biomarkers and cumulative effects on prognosis in patients with acute coronary syndromes J2 - Eur Heart J Suppl PY - 2010 VL - 12 SP - F19 ER - TY - JOUR LB - 178. AU - Ripley, AW AU - Narang, J AU - Fifi, J AU - Bennett, HL TI - Aspirin and clopidogrel resistance in patients requiring endovascular neurological intervention J2 - J Neurosurg Anesthesiol PY - 2010 VL - 22 SP - 437 ER - TY - JOUR LB - 179. AU - Kuliczkowski, W AU - Kaczmarski, J AU - Greif, M AU - Polonski, L AU - Gasior, M AU - Serebruany, V TI - Thrombin induced aggregation and 6-months outcome in patients with diabetes and STEMI treated with primary PCI J2 - Eur Heart J PY - 2010 VL - 31 SP - 972 ER - TY - JOUR LB - 180. AU - Bobescu, E AU - Radoi, M AU - Datcu, G AU - Dobreanu, D AU - Donea, M AU - Doka, B TI - Evaluation of platelets hyperactivity, hypercoagulability status and oxidative stress biomarkers and outcomes in patients with acute coronary syndromes J2 - Eur Heart J PY - 2010 VL - 31 SP - 971 EP - 972 ER - TY - JOUR LB - 181. AU - Fateh-Moghadam, S AU - Mueller, E AU - Ziemer, S AU - Dietz, R AU - Gawaz, M AU - Bocksch, W TI - Responsiveness to higher maintenance dose of dual antiplatelet therapy and its impact on stent thrombosis J2 - Eur Heart J PY - 2010 VL - 31 SP - 971 ER - TY - JOUR LB - 182. AU - Ko, YG AU - Suh, JW AU - Kim, JS AU - Choi, DH AU - Hong, MK AU - Jang, YS TI - Prognostic significance of dual hyporesponsiveness to aspirin and clopidogrel measured by verifynow assay in the patients undergoing percutaneous coronary intervention J2 - Eur Heart J PY - 2010 VL - 31 SP - 970 EP - 971 ER - TY - JOUR LB - 183. AU - Tokgoz, HC AU - Tanboga, IH AU - Can, MM AU - Bezgin, T AU - Akgun, T AU - Turkyilmaz, E TI - Does platelet response to clopidogrel and/or aspirin as assessed by multiplate analyser predict short and long-term outcome following coronary stenting? J2 - Eur Heart J PY - 2010 VL - 31 SP - 967 ER - TY - JOUR LB - 184. AU - Colic, M AU - Calija, B AU - Babic, T AU - Sarenac, D AU - Ljubic, M AU - Spasojevic, B TI - Exaggerated platelet hypo reactivity increases bleeding risk as measured by multiplate impedance aggregometry test after coronary stenting J2 - Eur Heart J PY - 2010 VL - 31 IS - Suppl. 1 SP - 204 ER - TY - JOUR LB - 185. AU - Catakoglu, AB AU - Aytekin, S AU - Celebi, H AU - Sener, M AU - Kurtoglu, H AU - Demiroglu, C TI - The influence of aspirin resistance on non-fatal coronary events following percutaneous coronary interventions J2 - Arch Med Sci PY - 2009 VL - 5 SP - 531 EP - 538 ER - TY - JOUR LB - 186. AU - Sobol, AB AU - Mochecka, A AU - Selmaj, K AU - Loba, J TI - Is there a relationship between aspirin responsiveness and clinical aspects of ischemic stroke? J2 - Adv Clin Exp Med PY - 2009 VL - 18 SP - 473 EP - 479 ER - TY - JOUR LB - 187. AU - Modica, A AU - Karlsson, F AU - Mooe, T TI - The impact of platelet function or C-reactive protein, on cardiovascular events after an acute myocardial infarction J2 - Thromb J PY - 2009 VL - 7 SP - 12 UR - http://dx.doi.org/10.1186/1477-9560-7-12 ER - TY - JOUR LB - 188. AU - Angiolillo, D AU - Bernardo, E AU - Capranzano, P AU - Sabate, M AU - Jimenez-Quevedo, P AU - Ferreiro, JL TI - Prognostic implications of high platelet reactivity as defined by multiple agonists in diabetes mellitus patients on dual antiplatelet therapy J2 - J Am Coll Cardiol PY - 2009 VL - 53 SP - A68 ER - TY - JOUR LB - 189. AU - Harrison, P AU - Silver, L AU - Segal, H AU - Syed, A AU - Mehta, Z AU - Rothwell, P TI - Long term prognostic value of aspirin non-responsiveness and platelet reactivity after acute vascular events: a population-base cohort study J2 - J Thromb Haemost PY - 2009 VL - 7 IS - Suppl. 2 SP - 104 ER - TY - JOUR LB - 190. AU - Range, G AU - Richard, P AU - Chassaing, S AU - Belle, L AU - Thuaire, C AU - Cazaux, P TI - Impact of low response to aspirin and/or clopidogrel in 1001 patients undergoing coronary stenting: 1-month results of the VERIFRENCHY registry J2 - Eur Heart J PY - 2009 VL - 30 SP - 858 UR - http://dx.doi.org/10.1016/j.acvd.2014.03.004 ER - TY - JOUR LB - 191. AU - Milicic, D AU - Lovric, D AU - Skoric, B AU - Samardzic, J AU - Gornik, I AU - Narancic, SK TI - Effects of lower platelet aspirin and clopidogrel response on long-term outcomes in patients with acute STEMI J2 - Eur Heart J PY - 2009 VL - 30 IS - Suppl. 1 SP - 193 UR - http://dx.doi.org/10.1016/j.ijcard.2011.09.055 ER - TY - JOUR LB - 192. AU - Vaduganathan, M AU - Guthikonda, S AU - Nure, B AU - Siqueiros-Garcia, A AU - Mangalpally, KR AU - Paranilam, J TI - Point-of-care measurement of aspirin responsiveness predicts long-term clinical outcomes in patients undergoing elective percutaneous coronary intervention J2 - Am J Cardiol PY - 2009 VL - 104 IS - Suppl. 1 SP - 174D UR - http://dx.doi.org/10.1016/j.amjcard.2009.08.501 ER - TY - JOUR LB - 193. AU - Silver, LE AU - Harrison, P AU - Segal, H AU - Syed, A AU - Mehta, Z AU - Rothwell, PM TI - Long-term prognostic value of aspirin non-responsiveness and platelet reactivity after acute vascular events: a population-based prospective cohort study J2 - Cerebrovasc Dis PY - 2009 VL - 27 IS - Suppl. 6 SP - 28 ER - TY - JOUR LB - 194. AU - Kim, S AU - Lee, DH AU - Lim, HK AU - Kwon, SU AU - Choi, CG AU - Suh, DC TI - Change of platelet reactivity to antiplatelet therapy after stenting procedure for cerebral artery stenosis: Verifynow antiplatelet assay before and after stenting J2 - Neuroradiology PY - 2009 VL - 51 SP - S43 ER - TY - JOUR LB - 195. AU - Eikelboom, JW AU - Hankey, GJ AU - Thom, J AU - Bhatt, DL AU - Steg, PG AU - Montalescot, G TI - Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk J2 - Circulation PY - 2008 VL - 118 SP - 1705 EP - 1712 UR - http://dx.doi.org/10.1161/CIRCULATIONAHA.108.768283 ER - TY - JOUR LB - 196. AU - Kaminska, M AU - Osada, J AU - Dabrowska, M AU - Kloczko, J AU - Kramkowski, K AU - Musial, WJ TI - The assessment of antiplatelet activity of aspirin among survivors of myocardial infarction treated with PCI in six months observation – preliminary results J2 - Pol Prz Kardiol PY - 2007 VL - 9 SP - 335 EP - 341 ER - TY - JOUR LB - 197. AU - Gurbel, PA AU - Bliden, KP AU - Navickas, I AU - Cohen, E AU - Tantry, US TI - Post-coronary intervention recurrent ischemia in the presence of adequate platelet inhibition by dual antiplatelet therapy: What are we overlooking? J2 - J Thromb Haemost PY - 2007 VL - 5 SP - 2300 EP - 2301 UR - http://dx.doi.org/10.1111/j.1538-7836.2007.02749.x ER - TY - JOUR LB - 198. AU - Stejskal, D AU - Vaclavik, J AU - Lacnak, B AU - Proskova, J TI - Aspirin resistance measured by cationic propyl gallate platelet aggregometry and recurrent cardiovascular events during 4 years of follow-up J2 - Eur J Intern Med PY - 2006 VL - 17 SP - 349 EP - 354 UR - http://dx.doi.org/10.1016/j.ejim.2006.01.006 ER - TY - JOUR LB - 199. AU - Sambu, N AU - Radhakrishnan, A AU - Dent, H AU - Calver, AL AU - Corbett, S AU - Gray, H TI - Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry J2 - Heart PY - 2012 VL - 98 SP - 706 EP - 711 UR - http://dx.doi.org/10.1136/heartjnl-2011-301164 ER - TY - JOUR LB - 200. AU - Lee, DH AU - Kim, HS AU - Kim, SM AU - Kwon, SU AU - Suh, DC TI - Change of platelet reactivity to antiplatelet therapy after stenting procedure for cerebral artery stenosis: VerifyNow antiplatelet assay before and after stenting J2 - Neurointervention PY - 2012 VL - 7 SP - 23 EP - 26 UR - http://dx.doi.org/10.5469/neuroint.2012.7.1.23 ER - TY - JOUR LB - 201. AU - Feng, XR AU - Liu, ML AU - Liu, F AU - Tian, QP AU - Fan, Y AU - Liu, QZ TI - Aspirin response and related factors in aged patients J2 - Chung-Hua Hsin Hsueh Kuan Ping Tsa Chih PY - 2011 VL - 39 SP - 925 EP - 928 ER - TY - JOUR LB - 202. AU - Eskandarian, R AU - Darabian, M TI - Impact of aspirin resistance on one year’s prognosis in chronic stable angina in Semnan – Iran J2 - Atheroscler Suppl PY - 2011 VL - 12 SP - 170 UR - http://dx.doi.org/10.1016/S1567-5688(11)70811-X ER - TY - JOUR LB - 203. AU - Verschuren, JJ AU - Trompet, S AU - Wessels, JA AU - Guchelaar, HJ AU - de Maat, MP AU - Simoons, ML TI - A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application? J2 - Eur Heart J PY - 2012 VL - 33 SP - 165 EP - 175 UR - http://dx.doi.org/10.1093/eurheartj/ehr239 ER - TY - JOUR LB - 204. AU - Dickinson, KJ AU - Troxler, M AU - Homer-Vanniasinkam, S TI - The surgical application of point-of-care haemostasis and platelet function testing J2 - Br J Surg PY - 2008 VL - 95 SP - 1317 EP - 1330 UR - http://dx.doi.org/10.1002/bjs.6359 ER - TY - JOUR LB - 205. AU - El-Menyar, A AU - Hussein, H AU - Al Suwaidi, J TI - Coronary stent thrombosis in patients with chronic renal insufficiency J2 - Angiology PY - 2010 VL - 61 SP - 297 EP - 303 UR - http://dx.doi.org/10.1177/0003319709344574 ER - TY - JOUR LB - 206. AU - Velkovic, J AU - Coulthard, A TI - The drugs don’t work: low response to antiplatelet agents in patients undergoing endovascular procedures J2 - J Med Imaging Radiat Oncol PY - 2009 VL - 53 SP - A275 ER - TY - JOUR LB - 207. AU - Crescente, M AU - Di Castelnuovo, A AU - Iacoviello, L AU - Vermylen, J AU - Cerletti, C AU - De Gaetano, G TI - Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review J2 - Thromb Haemost PY - 2008 VL - 99 SP - 14 EP - 26 UR - http://dx.doi.org/10.1160/TH07-08-0530 ER - TY - JOUR LB - 208. AU - Reny, JL AU - de Moerloose, P AU - Dauzat, M AU - Fontana, P TI - Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis J2 - J Thromb Haemost PY - 2008 VL - 6 SP - 444 EP - 450 UR - http://dx.doi.org/10.1111/j.1538-7836.2008.02897.x ER - TY - JOUR LB - 209. AU - Krasopoulos, G AU - Brister, SJ AU - Beattie, WS AU - Buchanan, MR TI - Aspirin ‘resistance’ and risk of cardiovascular morbidity: systematic review and meta-analysis J2 - BMJ PY - 2008 VL - 336 SP - 195 EP - 198 UR - http://dx.doi.org/10.1136/bmj.39430.529549.BE ER - TY - JOUR LB - 210. AU - Ferguson, AD AU - Dokainish, H AU - Lakkis, N TI - Aspirin and clopidogrel response variability: review of the published literature J2 - Tex Heart Inst J PY - 2008 VL - 35 SP - 313 EP - 320 ER - TY - JOUR LB - 211. AU - Sofi, F AU - Marcucci, R AU - Gori, AM AU - Abbate, R AU - Gensini, GF TI - Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events – a meta-analysis J2 - Int J Cardiol PY - 2008 VL - 128 SP - 166 EP - 171 UR - http://dx.doi.org/10.1016/j.ijcard.2007.12.010 ER - TY - JOUR LB - 212. AU - Musallam, KM AU - Charafeddine, K AU - Bitar, A AU - Khoury, M AU - Assaad, S AU - Beresian, J TI - Resistance to aspirin and clopidogrel therapy J2 - Int J Lab Hematol PY - 2011 VL - 33 SP - 1 EP - 18 UR - http://dx.doi.org/10.1111/j.1751-553X.2010.01268.x ER - TY - JOUR LB - 213. AU - Wong, S AU - Appleberg, M AU - Ward, CM AU - Lewis, DR TI - Aspirin resistance in cardiovascular disease: a review J2 - Eur J Vasc Endovasc Surg PY - 2004 VL - 27 SP - 456 EP - 465 UR - http://dx.doi.org/10.1016/j.ejvs.2003.12.025 ER - TY - JOUR LB - 214. AU - Howard, PA TI - Aspirin resistance J2 - Ann Pharmacother PY - 2002 VL - 36 SP - 1620 EP - 1624 UR - http://dx.doi.org/10.1345/aph.1C013 ER - TY - JOUR LB - 215. AU - Canivano, PL AU - Garcia, YC TI - Resistance to aspirin: prevalence, mechanisms of action and association with thromboembolic events. A narrative review J2 - Farm Hosp PY - 2010 VL - 34 SP - 32 EP - 43 UR - http://dx.doi.org/10.1016/j.farma.2009.08.002 ER - TY - JOUR LB - 216. AU - Pusch, G AU - Feher, G AU - Kotai, K AU - Tibold, A AU - Gasztonyi, B AU - Feher, A TI - Aspirin resistance: focus on clinical endpoints J2 - J Cardiovasc Pharmacol PY - 2008 VL - 52 SP - 475 EP - 484 UR - http://dx.doi.org/10.1097/FJC.0b013e31818eee5f ER - TY - JOUR LB - 217. AU - Snoep, JD AU - Hovens, MM AU - Eikenboom, JC AU - Van Der Bom, JG AU - Huisman, MV TI - Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis J2 - Arch Intern Med PY - 2007 VL - 167 SP - 1593 EP - 1599 UR - http://dx.doi.org/10.1001/archinte.167.15.1593 ER - TY - JOUR LB - 218. AU - Mansour, K AU - Taher, AT AU - Musallam, KM AU - Alam, S TI - Aspirin resistance J2 - Adv Hematol PY - 2009 VL - 2009 SP - 937352 UR - http://dx.doi.org/10.1155/2009/937352 ER - TY - JOUR LB - 219. AU - Gum, PA AU - Kottke-Marchant, K AU - Poggio, ED AU - Gurm, H AU - Welsh, PA AU - Brooks, L TI - Profile and prevalence of aspirin resistance in patients with cardiovascular disease J2 - Am J Cardiol PY - 2001 VL - 88 SP - 230 EP - 235 UR - http://dx.doi.org/10.1016/S0002-9149(01)01631-9 ER - TY - JOUR LB - 220. AU - Andersen, LA AU - Gormsen, J TI - Platelet aggregation and fibrinolytic activity in transient cerebral ischemia J2 - Acta Neurol Scand PY - 1976 VL - 55 SP - 76 EP - 82 UR - http://dx.doi.org/10.1111/j.1600-0404.1977.tb05628.x ER - TY - JOUR LB - 221. AU - Fritsma, GA AU - Ens, GE AU - Alvord, MA AU - Carroll, AA AU - Jensen, R TI - Monitoring the antiplatelet action of aspirin J2 - JAAPA PY - 2001 VL - 14 SP - 57 EP - 58 ER - TY - JOUR LB - 222. AU - Jilma, B TI - Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction J2 - J Lab Clin Med PY - 2001 VL - 138 SP - 152 EP - 163 UR - http://dx.doi.org/10.1067/mlc.2001.117406 ER - TY - JOUR LB - 223. AU - Favaloro, EJ TI - Clinical application of the PFA-100 J2 - Curr Opin Hematol PY - 2002 VL - 9 SP - 407 EP - 415 UR - http://dx.doi.org/10.1097/00062752-200209000-00004 ER - TY - JOUR LB - 224. AU - Escolar, G AU - Cases, A AU - Vinas, M AU - Pino, M AU - Calls, J AU - Cirera, I TI - Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyser (PFA 100TM): Influence of hematocrit elevation J2 - Haematologica PY - 1999 VL - 84 SP - 614 EP - 619 ER - TY - JOUR LB - 225. AU - Borna, C AU - Lazarowski, E AU - van Heusden, C AU - Ohlin, H AU - Erlinge, D TI - Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels J2 - Thromb J PY - 2005 VL - 3 SP - 10 UR - http://dx.doi.org/10.1186/1477-9560-3-10 ER - TY - JOUR LB - 226. AU - Sathiropas, P TI - Detection of small inhibitory effects on acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood J2 - Thromb Res PY - 1988 VL - 51 SP - 55 EP - 62 UR - http://dx.doi.org/10.1016/0049-3848(88)90282-4 ER - TY - JOUR LB - 227. AU - Friend, M AU - Vucenik, I AU - Miller, M TI - Platelet responsiveness to aspirin in patients with hyperlipidemia J2 - BMJ PY - 2003 VL - 326 SP - 82 EP - 83 UR - http://dx.doi.org/10.1136/bmj.326.7380.82 ER - TY - JOUR LB - 228. AU - Korpanty, A AU - Ravindra, S AU - Yassin, J AU - Frenkel, EP TI - Sensitivity of whole blood aggregation, platelet rich plasma, and platelet function analyzer in detection aspirin effect on platelet function J2 - J Am Soc Hematol PY - 2002 VL - 100 SP - 11 ER - TY - JOUR LB - 229. AU - Korpanty, A AU - Frenkel, EP AU - Sarode, R TI - An approach to the assessment of platelet function: comparison of optical platelet rich and impedance whole blood aggregation methods J2 - Thromb Hemost PY - 2005 VL - 11 SP - 25 EP - 35 UR - http://dx.doi.org/10.1177/107602960501100103 ER - TY - JOUR LB - 230. AU - Ivandic, B AU - Giannitis, E AU - Schlick, P AU - Staritz, P AU - Katus, H AU - Hohlfeld, T TI - Determination of aspirin responsiveness by use of whole blood platelet aggregometry J2 - Clin Chem PY - 2007 VL - 53 SP - 614 EP - 619 UR - http://dx.doi.org/10.1373/clinchem.2006.081059 ER - TY - JOUR LB - 231. AU - Poston, RS AU - White, C AU - Gu, J AU - Brown, J AU - Gammie, J AU - Pierson, RN TI - Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting J2 - Ann Thorac Surg PY - 2006 VL - 81 SP - 104 EP - 110 UR - http://dx.doi.org/10.1016/j.athoracsur.2005.05.085 ER - TY - JOUR LB - 232. AU - Haude, M AU - Hafner, G AU - Jablonka, A AU - Rupprecht, HJ AU - Prellwitz, W AU - Meyer, J TI - Guidance of anticoagulation after intracoronary implantation of Palmaz-Schatz stents by monitoring prothrombin and prothrombin fragment 1 + 2 J2 - Am Heart J PY - 1995 VL - 130 SP - 228 EP - 238 UR - http://dx.doi.org/10.1016/0002-8703(95)90433-6 ER - TY - JOUR LB - 233. AU - Grotemeyer, KH TI - The platelet-reactivity-test – a useful ‘by-product’ of the blood-sampling procedure? J2 - Thromb Res PY - 1991 VL - 61 SP - 423 EP - 431 UR - http://dx.doi.org/10.1016/0049-3848(91)90656-H ER - TY - JOUR LB - 234. AU - Grotemeyer, KH TI - Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients J2 - Thromb Res PY - 1991 VL - 63 SP - 587 EP - 593 UR - http://dx.doi.org/10.1016/0049-3848(91)90085-B ER - TY - JOUR LB - 235. AU - Zhang, Y AU - Liang, J AU - Zhou, YJ AU - Yuan, H AU - Zhang, YZ AU - Dong, L J2 - Chung-Hua Hsin Hsueh Kuan Ping Tsa Chih PY - 2005 VL - 33 SP - 695 EP - 699 ER - TY - JOUR LB - 236. AU - Yilmaz, MB AU - Balbay, Y AU - Caldir, V AU - Ayaz, S AU - Guray, Y AU - Guray, U TI - Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance J2 - Thromb Res PY - 2005 VL - 115 SP - 25 EP - 29 UR - http://dx.doi.org/10.1016/j.thromres.2004.07.004 ER - TY - JOUR LB - 237. AU - Valles, J AU - Santos, MT AU - Fuset, MP AU - Moscardo, A AU - Ruano, M AU - Perez, F TI - Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction J2 - Am J Cardiol PY - 2007 VL - 99 SP - 19 EP - 25 UR - http://dx.doi.org/10.1016/j.amjcard.2006.07.058 ER - TY - JOUR LB - 238. AU - Malek, LA AU - Spiewak, M AU - Filipiak, KJ AU - Grabowski, M AU - Szpotanska, M AU - Rosiak, M TI - Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes J2 - Kardiol Pol PY - 2007 VL - 65 SP - 40 EP - 45 ER - TY - JOUR LB - 239. AU - Lev, EI AU - Patel, RT AU - Maresh, KJ AU - Guthikonda, S AU - Granada, J AU - DeLao, T TI - Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance J2 - J Am Coll Cardiol PY - 2006 VL - 47 SP - 27 EP - 33 UR - http://dx.doi.org/10.1016/j.jacc.2005.08.058 ER - TY - JOUR LB - 240. AU - Hobikoglu, GF AU - Norgaz, T AU - Aksu, H AU - Ozer, O AU - Erturk, M AU - Nurkalem, Z TI - High frequency of aspirin resistance in patients with acute coronary syndrome J2 - Tohoku J Exp Med PY - 2005 VL - 207 SP - 59 EP - 64 UR - http://dx.doi.org/10.1620/tjem.207.59 ER - TY - JOUR LB - 241. AU - Faraday, N AU - Braunstein, JB AU - Heldman, AW AU - Bolton, ED AU - Chiles, KA AU - Gerstenblith, G TI - Prospective evaluation of the relationship between platelet–leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes J2 - Platelets PY - 2004 VL - 15 SP - 9 EP - 14 UR - http://dx.doi.org/10.1080/09537100310001644006 ER - TY - JOUR LB - 242. AU - Chen, W-H AU - Lee, P-Y AU - Ng, W AU - Tse, H-F AU - Lau, C-P TI - Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment J2 - J Am Coll Cardiol PY - 2004 VL - 43 SP - 1122 EP - 1126 UR - http://dx.doi.org/10.1016/j.jacc.2003.12.034 ER - TY - JOUR LB - 243. AU - Chen, W-H AU - Lee, P-Y AU - Ng, W AU - Kwok, JYY AU - Cheng, X AU - Lee, SWL TI - Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary Intervention J2 - Am J Cardiol PY - 2005 VL - 96 SP - 760 EP - 763 UR - http://dx.doi.org/10.1016/j.amjcard.2005.04.056 ER - TY - JOUR LB - 244. AU - Andersen, K AU - Hurlen, M AU - Arnesen, H AU - Seljeflot, I TI - Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease J2 - Thromb Res PY - 2002 VL - 108 SP - 37 EP - 42 UR - http://dx.doi.org/10.1016/S0049-3848(02)00405-X ER - TY - JOUR LB - 245. AU - Atiemo, AD AU - Ng’Alla, LS AU - Vaidya, D AU - Williams, MS TI - Abnormal PFA-100 closure time is associated with increased platelet aggregation in patients presenting with chest pain J2 - J Thromb Thrombolysis PY - 2008 VL - 25 SP - 173 EP - 178 UR - http://dx.doi.org/10.1007/s11239-007-0045-5 ER - TY - JOUR LB - 246. AU - Berrouschot, J AU - Schwetlick, B AU - von Twickel, G AU - Fischer, C AU - Uhlemann, H AU - Siegemund, T TI - Aspirin resistance in secondary stroke prevention J2 - Acta Neurol Scand PY - 2006 VL - 113 SP - 31 EP - 35 UR - http://dx.doi.org/10.1111/j.1600-0404.2005.00419.x ER - TY - JOUR LB - 247. AU - Poston, RS AU - Gu, J AU - Brown, JM AU - Gammie, JS AU - White, C AU - Nie, L TI - Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting J2 - J Thorac Cardiovasc Surg PY - 2006 VL - 131 SP - 122 EP - 130 UR - http://dx.doi.org/10.1016/j.jtcvs.2005.08.058 ER - TY - JOUR LB - 248. AU - Grundmann, K AU - Jaschonek, K AU - Kleine, B AU - Dichgans, J AU - Topka, H TI - Aspirin non-responder status in patients with recurrent cerebral ischemic attacks J2 - J Neurol PY - 2003 VL - 250 SP - 63 EP - 66 UR - http://dx.doi.org/10.1007/s00415-003-0954-y ER - TY - JOUR LB - 249. AU - McCabe, DJ AU - Harrison, P AU - Mackie, IJ AU - Sidhu, PS AU - Lawrie, AS AU - Purdy, G TI - Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA J2 - Platelets PY - 2005 VL - 16 SP - 269 EP - 280 UR - http://dx.doi.org/10.1080/09537100400020567 ER - TY - JOUR LB - 250. AU - Poulsen, TS AU - Jørgensen, B AU - Korsholm, L AU - Licht, PB AU - Haghfelt, T AU - Mickley, H TI - Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction J2 - Thromb Res PY - 2007 VL - 119 SP - 555 EP - 562 UR - http://dx.doi.org/10.1016/j.thromres.2006.04.005 ER - TY - JOUR LB - 251. AU - Pamukcu, B AU - Oflaz, H AU - Nisanci, Y TI - The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis J2 - Am Heart J PY - 2005 VL - 149 SP - 675 EP - 680 UR - http://dx.doi.org/10.1016/j.ahj.2004.10.007 ER - TY - JOUR LB - 252. AU - Linden, MD AU - Furman, MI AU - Frelinger, AL, III AU - Fox, ML AU - Barnard, MR AU - Li, Y TI - Indices of platelet activation and the stability of coronary artery disease J2 - J Thromb Haemost PY - 2007 VL - 5 SP - 761 EP - 765 UR - http://dx.doi.org/10.1111/j.1538-7836.2007.02462.x ER - TY - JOUR LB - 253. AU - Gulmez, O AU - Yildirir, A AU - Kaynar, G AU - Konas, D AU - Aydinalp, A AU - Ertan, C TI - Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions J2 - J Thromb Thrombolysis PY - 2007 VL - 25 SP - 239 EP - 246 UR - http://dx.doi.org/10.1007/s11239-007-0067-z ER - TY - JOUR LB - 254. AU - Cornelissen, J AU - Kirtland, S AU - Lim, E AU - Goddard, M AU - Bellm, S AU - Sheridan, K TI - Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function J2 - Thromb Haemost PY - 2006 VL - 95 SP - 476 EP - 482 ER - TY - JOUR LB - 255. AU - Cheng, X AU - Chen, WH AU - Lee, PY AU - Ng, W AU - Kwok, YY AU - Lau, CP TI - Prevalence, profile, predictors, and natural history of aspirin resistance measured by the Ultegra Rapid Platelet Function Assay-ASA in patients with coronary heart disease J2 - Circulation PY - 2005 VL - 111 SP - E339 ER - TY - JOUR LB - 256. AU - Geisler, T AU - Kapp, M AU - Gohring-Frischholz, K AU - Daub, K AU - Dosch, C AU - Bigalke, B TI - Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease J2 - Heart PY - 2008 VL - 94 SP - 743 EP - 747 UR - http://dx.doi.org/10.1136/hrt.2006.100891 ER - TY - JOUR LB - 257. AU - Gurbel, PA AU - Bliden, KP AU - Hiatt, BL AU - O’Connor, CM TI - Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity J2 - Circulation PY - 2003 VL - 107 SP - 2908 EP - 2913 UR - http://dx.doi.org/10.1161/01.CIR.0000072771.11429.83 ER - TY - ELEC LB - 258. AU - ClinicalTrials.gov TI - Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia UR - http://ClinicalTrials.gov/show/NCT01104441 M1 - 2 April 2012 ER - TY - ELEC LB - 259. AU - ClinicalTrials.gov TI - Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting UR - http://ClinicalTrials.gov/show/NCT01159639 M1 - 2 April 2012 ER - TY - ELEC LB - 260. AU - ClinicalTrials.gov TI - Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery UR - http://ClinicalTrials.gov/show/NCT01174862 M1 - 2 April 2012 ER - TY - ELEC LB - 261. AU - ClinicalTrials.gov TI - Resistance to Aspirin and/or Clopidogrel Among Patients With PAD UR - http://ClinicalTrials.gov/show/NCT00262561 M1 - 2 April 2012 ER - TY - ELEC LB - 262. AU - ClinicalTrials.gov TI - The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study) UR - http://clinicaltrials.gov/ct2/show/study/NCT00250380 M1 - 2 April 2012 ER - TY - ELEC LB - 263. AU - ClinicalTrials.gov TI - Evaluation and Comparison of Several Point-of-Care Platelet Function Tests in Predicting Clinical Outcomes in Clopidogrel Pre-Treated Patients Undergoing Elective PCI UR - http://ClinicalTrials.gov/show/NCT00352014 M1 - 2 April 2012 ER - TY - ELEC LB - 264. AU - ClinicalTrials.gov TI - Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study UR - https://clinicaltrials.gov/show/NCT00330772 M1 - 2 April 2012 ER - TY - JOUR LB - 265. AU - Reny, JL AU - Berdague, P AU - Poncet, A AU - Barazer, I AU - Nolli, S AU - Fabbro-Peray, P TI - Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the ADRIE study J2 - Circulation PY - 2012 VL - 125 SP - 3201 EP - 3210 UR - http://dx.doi.org/10.1161/CIRCULATIONAHA.111.085464 ER - TY - JOUR LB - 266. AU - Collet, J-P AU - Cuisset, T AU - Rangé, G AU - Cayla, G AU - Elhadad, S AU - Pouillot, C TI - Bedside monitoring to adjust antiplatelet therapy for coronary stenting J2 - New Engl J Med PY - 2012 VL - 367 SP - 2100 EP - 2109 UR - http://dx.doi.org/10.1056/NEJMoa1209979 ER - TY - JOUR LB - 267. AU - Yamane, K AU - Taniguchi, R AU - Watanabe, S AU - Kawato, M AU - Shirakawa, R AU - Higashi, T TI - Impact of platelet reactivity on long-term clinical outcomes and bleeding events in Japanese patients receiving antiplatelet therapy with aspirin J2 - J Atheroscler Thromb PY - 2012 VL - 19 SP - 1142 EP - 1153 UR - http://dx.doi.org/10.5551/jat.14100 ER - TY - JOUR LB - 268. AU - Evers, S AU - Goossens, M AU - de Vet, H AU - van Tulder, M AU - Ament, A TI - Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria J2 - Int J Technol Assess Health Care PY - 2005 VL - 21 SP - 240 EP - 245 ER - TY - JOUR LB - 269. AU - Philips, Z AU - Bojke, L AU - Sculpher, M AU - Claxton, K AU - Golder, S TI - Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment J2 - Pharmacoeconomics PY - 2006 VL - 24 SP - 355 EP - 371 UR - http://dx.doi.org/10.2165/00019053-200624040-00006 ER - TY - JOUR LB - 270. AU - Bronnum-Hansen, H AU - Davidsen, M AU - Thorvaldsen, P TI - Long-term survival and causes of death after stroke J2 - Stroke PY - 2001 VL - 32 SP - 2131 EP - 2136 UR - http://dx.doi.org/10.1161/hs0901.094253 ER - TY - JOUR LB - 271. AU - Bronnum-Hansen, H AU - Jorgensen, T AU - Davidsen, M AU - Madsen, M AU - Osler, M AU - Gerdes, LU TI - Survival and cause of death after myocardial infarction: the Danish MONICA study J2 - J Clin Epidemiol PY - 2001 VL - 54 SP - 1244 EP - 1250 UR - http://dx.doi.org/10.1016/S0895-4356(01)00405-X ER - TY - BOOK LB - 272. AU - Joint Formulary Committee TI - British National Formulary CY - London PB - BMJ Group and Pharmaceutical Press PY - 2013 ER - TY - BOOK LB - 273. AU - Department of Health TI - NHS Reference Costs: Financial Year 2011 to 2012 CY - London PB - Department of Health PY - 2012 ER - TY - JOUR LB - 274. AU - Robinson, M AU - Palmer, S AU - Sculpher, MJ AU - Philips, Z AU - Ginnelly, L AU - Bowens, A TI - Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision analytic modelling J2 - Health Technol Assess PY - 2005 VL - 9 IS - 27 UR - http://dx.doi.org/10.3310/hta9270 ER - TY - JOUR LB - 275. AU - Youman, P AU - Wilson, K AU - Harraf, F AU - Kalra, L TI - The economic burden of stroke in the United Kingdom J2 - Pharmacoeconomics PY - 2003 VL - 21 IS - Suppl. 1 SP - 43 EP - 50 UR - http://dx.doi.org/10.2165/00019053-200321001-00005 ER - TY - JOUR LB - 276. AU - Greenhalgh, J AU - Bagust, A AU - Boland, A AU - Martin, SC AU - Oyee, J AU - Blundell, M TI - Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis J2 - Health Technol Assess PY - 2011 VL - 15 IS - 31 UR - http://dx.doi.org/10.3310/hta15310 ER - TY - BOOK LB - 277. AU - Cooper, A AU - Nherera, L AU - Calvert, N AU - O’Flynn, N AU - Turnbull, N AU - Robson, J TI - Clinical Guidelines and Evidence Review for Lipid Modification: Cardiovascular Risk Assessment and the Primary and Secondary Prevention of Cardiovascular Disease CY - London PB - National Collaborating Centre for Primary Care and Royal College of General Practitioners PY - 2008 ER - TY - JOUR LB - 278. AU - Ward, S AU - Lloyd, JM AU - Pandor, A AU - Holmes, M AU - Ara, R AU - Ryan, A TI - A systematic review and economic evaluation of statins for the prevention of coronary events J2 - Health Technol Assess PY - 2007 VL - 11 IS - 14 UR - http://dx.doi.org/10.3310/hta11140 ER - TY - BOOK LB - 279. AU - Office for National Statistics TI - Statistical Bulletin: Deaths Registered in England and Wales, 2012 CY - Newport PB - Office for National Statistics PY - 2012 ER - TY - BOOK LB - 280. AU - Kind, P AU - Hardman, G AU - Macran, S TI - UK Population Norms for EQ-5D CY - York PB - Centre for Health Economics, University of York PY - 1999 ER - TY - BOOK LB - 281. AU - National Institute for Health and Care Excellence (NICE) TI - The Guidelines Manual CY - London PB - NICE PY - 2012 ER - TY - JOUR LB - 282. AU - Lordkipanidzé, M AU - Diodati, JG AU - Schampaert, E AU - Palisaitis, DA AU - Pharand, C TI - Prevalence of unresponsiveness to aspirin and/or clopidogrel in patients with stable coronary heart disease J2 - Am J Cardiol PY - 2009 VL - 104 SP - 1189 EP - 1193 UR - http://dx.doi.org/10.1016/j.amjcard.2009.06.025 ER - TY - JOUR LB - 283. AU - Fontana, P AU - Nolli, S AU - Reber, G AU - de Moerloose, P TI - Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers J2 - J Thromb Haemost PY - 2006 VL - 4 SP - 813 EP - 819 UR - http://dx.doi.org/10.1111/j.1538-7836.2006.01867.x ER - TY - JOUR LB - 284. AU - Cuisset, T AU - Frere, C AU - Quilici, J AU - Morange, PE AU - Camoin, L AU - Bali, L TI - Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response J2 - Thromb Res PY - 2009 VL - 123 SP - 597 EP - 603 UR - http://dx.doi.org/10.1016/j.thromres.2008.04.003 ER - TY - JOUR LB - 285. AU - Royston, P AU - Altman, DG AU - Sauerbrei, W TI - Dichotomizing continuous predictors in multiple regression: a bad idea J2 - Stat Med PY - 2006 VL - 25 SP - 127 EP - 141 UR - http://dx.doi.org/10.1002/sim.2331 ER - TY - JOUR LB - 286. AU - Riley, RD AU - Lambert, PC AU - Abo, G TI - Meta-analysis of individual participant data: rationale, conduct, and reporting J2 - BMJ PY - 2010 VL - 340 SP - 410 EP - 414 UR - http://dx.doi.org/10.1136/bmj.c221 ER - TY - JOUR LB - 287. AU - Blettner, M AU - Sauerbrei, W AU - Schlehofer, B AU - Scheuchenpflug, T AU - Friedenreich, C TI - Traditional reviews, meta-analyses and pooled analyses in epidemiology J2 - Int J Epidemiol PY - 1999 VL - 28 SP - 1 EP - 9 UR - http://dx.doi.org/10.1093/ije/28.1.1 ER - TY - CHAP LB - 288. AU - Altman, DG AU - Trivella, M AU - Pezzella, F AU - Harris, AL AU - Pastorino, U TI - Systematic review of multiple studies of prognosis: the feasibility of obtaining individual patient data A2 - Auget, J-L A2 - Balakrishnan, N A2 - Mesbah, M A2 - Molenberghs, G T2 - Advances in Statistical Methods for the Health Sciences CY - Boston, MA PB - Birkhauser PY - 2006 SP - 3 EP - 18 ER - TY - JOUR LB - 289. AU - Kyzas, PA AU - Loizou, KT AU - Ioannidis, JPA TI - Selective reporting biases in cancer prognostic factor studies J2 - J Natl Cancer Inst PY - 2005 VL - 97 SP - 1043 EP - 1055 UR - http://dx.doi.org/10.1093/jnci/dji184 ER - TY - JOUR LB - 290. AU - Hemingway, H AU - Riley, RD AU - Altman, DG TI - Ten steps towards improving prognosis research J2 - BMJ PY - 2009 VL - 339 SP - b4184 UR - http://dx.doi.org/10.1136/bmj.b4184 ER - TY - JOUR LB - 291. AU - Riley, RD AU - Abrams, KR AU - Sutton, AJ AU - Lambert, PC AU - Jones, DR AU - Heney, D TI - Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future J2 - Br J Cancer PY - 2003 VL - 88 SP - 1191 EP - 1198 UR - http://dx.doi.org/10.1038/sj.bjc.6600886 ER - TY - JOUR LB - 292. AU - Altman, DG AU - Lausen, B AU - Sauerbrei, W AU - Schumacher, M TI - Dangers of using ‘optimal’ cutpoints in the evaluation of prognostic factors J2 - J Natl Cancer Inst PY - 1994 VL - 86 SP - 829 EP - 835 UR - http://dx.doi.org/10.1093/jnci/86.11.829 ER - TY - JOUR LB - 293. AU - Riley, RD AU - Hayden, JA AU - Steyerberg, EW AU - Moons, KG AU - Abrams, K AU - Kyzas, PA TI - Prognosis research strategy (PROGRESS) 2: prognostic factor research J2 - PLOS Med PY - 2013 VL - 10 SP - e1001380 UR - http://dx.doi.org/10.1371/journal.pmed.1001380 ER - TY - JOUR LB - 294. AU - Hemingway, H AU - Croft, P AU - Perel, P AU - Hayden, JA AU - Abrams, K AU - Timmis, A TI - Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes J2 - BMJ PY - 2013 VL - 346 SP - e5595 UR - http://dx.doi.org/10.1136/bmj.e5595 ER - TY - JOUR LB - 295. AU - Steyerberg, EW AU - Moons, KG AU - van der Windt, DA AU - Hayden, JA AU - Perel, P AU - Schroter, S TI - Prognosis research strategy (PROGRESS) 3: prognostic model research J2 - PLOS Med PY - 2013 VL - 10 SP - e1001381 UR - http://dx.doi.org/10.1371/journal.pmed.1001381 ER - TY - JOUR LB - 296. AU - Hingorani, AD AU - Windt, DA AU - Riley, RD AU - Abrams, K AU - Moons, KG AU - Steyerberg, EW TI - Prognosis research strategy (PROGRESS) 4: stratified medicine research J2 - BMJ PY - 2013 VL - 346 SP - e5793 UR - http://dx.doi.org/10.1136/bmj.e5793 ER - TY - JOUR LB - 297. AU - Rifai, N AU - Altman, DG AU - Bossuyt, PM TI - Reporting bias in diagnostic and prognostic studies: time for action J2 - Clin Chem PY - 2008 VL - 54 SP - 1101 EP - 1103 UR - http://dx.doi.org/10.1373/clinchem.2008.108993 ER - TY - CHAP LB - 298. AU - Simon, R AU - Sobin, LH TI - Evaluating prognostic factor studies T2 - TNM Online PB - John Wiley & Sons PY - 2003 UR - http://onlinelibrary.wiley.com/doi/10.1002/0471463736.tnmp04/abstract;jsessionid=360A7A5DF057D84D94606C0A801173E1.f02t03 Y2 - 24 March 2015 ER - TY - JOUR LB - 299. AU - Riley, RD AU - Burchill, SA AU - Abrams, KR AU - Heney, D AU - Lambert, PC AU - Jones, DR TI - A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing’s sarcoma and neuroblastoma J2 - Health Technol Assess PY - 2003 VL - 7 IS - 5 UR - http://dx.doi.org/10.3310/hta7050 ER - TY - JOUR LB - 300. AU - Kyzas, PA AU - Denaxa-Kyza, D AU - Ioannidis, JP TI - Almost all articles on cancer prognostic markers report statistically significant results J2 - Eur J Cancer PY - 2007 VL - 43 SP - 2559 EP - 2579 UR - http://dx.doi.org/10.1016/j.ejca.2007.08.030 ER - TY - JOUR LB - 301. AU - Altman, DG J2 - BMJ PY - 2001 VL - 323 SP - 224 EP - 228 UR - http://dx.doi.org/10.1136/bmj.323.7306.224 ER - TY - JOUR LB - 302. AU - Malats, N AU - Bustos, A AU - Nascimento, CM AU - Fernandez, F AU - Rivas, M AU - Puente, D TI - P53 as a prognostic marker for bladder cancer: a meta-analysis and review J2 - Lancet Oncol PY - 2005 VL - 6 SP - 678 EP - 686 UR - http://dx.doi.org/10.1016/S1470-2045(05)70315-6 ER - TY - JOUR LB - 303. AU - Hemingway, H AU - Philipson, P AU - Chen, R AU - Fitzpatrick, NK AU - Damant, J AU - Shipley, M TI - Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease J2 - PLOS Med PY - 2010 VL - 7 SP - e1000286 UR - http://dx.doi.org/10.1371/journal.pmed.1000286 ER - TY - JOUR LB - 304. AU - Sauerbrei, W TI - Prognostic factors. Confusion caused by bad quality design, analysis and reporting of many studies J2 - Adv Otorhinolaryngol PY - 2005 VL - 62 SP - 184 EP - 200 ER - TY - JOUR LB - 305. AU - Altman, DG AU - Lyman, GH TI - Methodological challenges in the evaluation of prognostic factors in breast cancer J2 - Breast Cancer Res Treat PY - 1998 VL - 52 SP - 289 EP - 303 UR - http://dx.doi.org/10.1023/A:1006193704132 ER - TY - JOUR LB - 306. AU - Simon, R AU - Altman, DG TI - Statistical aspects of prognostic factor studies in oncology J2 - Br J Cancer PY - 1994 VL - 69 SP - 979 EP - 985 UR - http://dx.doi.org/10.1038/bjc.1994.192 ER - TY - JOUR LB - 307. AU - Debray, TP AU - Moons, KG AU - Ahmed, I AU - Koffijberg, H AU - Riley, RD TI - A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis J2 - Stat Med PY - 2013 VL - 32 SP - 3158 EP - 3180 UR - http://dx.doi.org/10.1002/sim.5732 ER - TY - JOUR LB - 308. AU - Reitsma, JB AU - Glas, AS AU - Rutjes, AWS AU - Scholten, RJPM AU - Bossuyt, PM AU - Zwinderman, AH TI - Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews J2 - J Clin Epidemiol PY - 2005 VL - 58 SP - 982 EP - 990 UR - http://dx.doi.org/10.1016/j.jclinepi.2005.02.022 ER -